Created by Hipal
Last edited February 19, 2026
imported>Hipal
Fake COVID-19 treatment: quickly finishing - needs a thorough review for redundancies, timeline, etc
 
Vemareddy (talk | contribs)
brief update formatting based on references further and fixed typos after review
 
Line 1: Line 1:
{{short description|Indian consumer goods company}}
{{short description|Indian multinational conglomerate company}}
{{multiple issues|
{{advert|date=May 2021}}
{{COI|date=May 2021}}
{{copy edit|date=May 2021}}
{{More citations needed|date=May 2021}}
}}
{{tone|date=September 2021}}
{{Use dmy dates|date=January 2016}}
{{Use dmy dates|date=January 2016}}
{{Use Indian English|date=January 2016}}
{{Use Indian English|date=January 2016}}
{{cleanup rewrite|date=January 2024}}
{{Infobox company
{{Infobox company
| name = Patanjali Ayurveda
| name = Patanjali Ayurved
| logo_size = 250px
| logo = Patanjali Logo.svg
| founded = {{start date and age|df=yes|2006}}
| logo_size =  
| type = [[Privately held company|Private]]<ref>{{cite news|title=Patanjali CEO Acharya Balkrishna Among India's Richest: ChaMagazine|url=http://www.ndtv.com/india-news/patanjali-ceo-acharya-balkrishna-among-indias-richest-businessmen-chinese-magazine-1460074|access-date=10 January 2017|agency=NDTV|publisher=NDTV|date=18 September 2016}}</ref>
| founded = {{start date and age|df=yes|2006|}}
| type = [[Privately held company|Private]]<ref>{{cite news|title=Patanjali CEO Acharya Balkrishna Among India's Richest: ChaMagazine|url=http://www.ndtv.com/india-news/patanjali-ceo-acharya-balkrishna-among-indias-richest-businessmen-chinese-magazine-1460074|access-date=10 January 2017|agency=NDTV|publisher=NDTV|date=18 September 2016|archive-date=27 September 2022|archive-url=https://web.archive.org/web/20220927180515/https://www.ndtv.com/india-news/patanjali-ceo-acharya-balkrishna-among-indias-richest-businessmen-chinese-magazine-1460074|url-status=live}}</ref>
| founder = {{plainlist|  
| founder = {{plainlist|  
*[[Balkrishna]]
*[[Balkrishna|Acharya Balkrishna]]
*[[Ramdev]]}}
*[[Ramdev|Baba Ramdev]]}}
| key_people = [[Balkrishna]]<br />{{small|(chairperson, managing director & CEO)}}
| area_served = {{plainlist|
| area_served = {{plainlist|
* Worldwide
* Worldwide
*[[Indian Subcontinent]]
*[[Indian subcontinent]]
*[[Middle East]]}}<ref name="Firstpostxx2016">{{cite web | title=Patanjali to launch 'Swadeshi' jeans soon, exploring global markets with FMCG | website=Firstpost | date=12 September 2016 | url=http://www.firstpost.com/business/patanjali-to-launch-desi-jeans-by-year-end-explore-global-markets-with-fmcg-3000214.html | access-date=4 December 2016}}</ref>
*[[Middle East]]}}<ref name="Firstpostxx2016">{{cite web | title=Patanjali to launch 'Swadeshi' jeans soon, exploring global markets with FMCG | website=Firstpost | date=12 September 2016 | url=http://www.firstpost.com/business/patanjali-to-launch-desi-jeans-by-year-end-explore-global-markets-with-fmcg-3000214.html | access-date=4 December 2016 | archive-date=7 May 2023 | archive-url=https://web.archive.org/web/20230507064701/https://www.firstpost.com/business/patanjali-to-launch-desi-jeans-by-year-end-explore-global-markets-with-fmcg-3000214.html | url-status=live }}</ref>
| industry = {{plainlist|
| industry = [[Conglomerate (company)|Conglomerate]]
*[[Fast moving consumer goods|Consumer goods]]
*[[Healthcare]]}}
| products = {{plainlist|
| products = {{plainlist|
*[[Food]]s
*[[beverage]]s
*[[cleaning agent]]s
*[[personal care products]]
*[[Ayurveda|Ayurvedic medicine]]
*[[Ayurveda|Ayurvedic medicine]]
*[[Fashion]]}}
*[[Fast-moving consumer goods|Consumer goods]]
| profit = {{increase}} ₹590 crore (US$80 million) (FY 2021)
*[[Healthcare]]
| revenue = {{increase}} ₹30,000 crore (US$4.02 billion) (FY 2021 )
*[[Personal care]]
| assets = {{increase}} ₹4,345 crore (US$590 million)
*[[Cosmetics]]
| assets_year = 2019
*[[Cleaning agent]]s
*[[Beverage]]s
*[[Fashion]]
*[[Food]]s}}
| revenue = {{up}}{{INRConvert|9872|c}} (2021)<ref name=RILFY>{{Cite web|url=https://www.moneycontrol.com/news/business/companies/patanjali-ayurved-clocked-14-jump-in-profit-in-fy21-tofler-data-7602111.html |title=Patanjali Ayurved clocked 14% jump in profit in FY21: Tofler data|year=2023}}</ref>
| profit = {{up}}{{INRConvert|485|c}} (2021)<ref name=RILFY/>
| assets =  
| assets_year =  
| subsid = {{plainlist|
| subsid = {{plainlist|
*[[Paridhan]]
* [[Patanjali Foods]]
*[[Ruchi Soya]]
* Patanjali Paridhan
*Herboved, Inc.
* Patanjali Renewable
*Advance Navigation and Solar Technologies Pvt. Ltd.}}
* Herboved
| num_employees = 2,00,000 (2011–12)<ref>{{cite news|url=http://www.ibtl.in/video/6507/employment-for-more-than-2-lac-food-herbal-park-patanjali-ayurved|title=Employment for more than 2 lac : Food & Herbal Park, Patanjali Ayurved|publisher=IBTL|date=22 September 2012}}</ref>
* Advance Navigation and Solar Technologies
| location_city = [[Haridwar, Uttarakhand]]
* [[University of Patanjali|Patanjali University]]}}
| location_country = [[India]]
| num_employees = 6,395 (November 2023)<ref>{{cite web |title=Patanjali Ayurved |url=https://tracxn.com/d/companies/patanjali-ayurved/__mO1xd0wWgBmWZRGfLVWa_peOKVh8DbzhNmoMlrTIfj8 |website=Tracxn |access-date=9 May 2024 |language=en |date=4 May 2024}}</ref>
| owner = [[Balkrishna]] (99.4%)
| location_city = [[Haridwar]], [[Uttarakhand]]
| website = {{URL|http://www.patanjaliayurved.org}}
| location_country = India
| owner = [[Balkrishna]] (94%)
| website = {{official URL}}
}}
}}
'''Patanjali Ayurved''', (commonly known as '''Patanjali),''' is an [[India]]n [[Multinational corporation|multinational]] [[consumer packaged goods]] company based in [[Haridwar]], [[India]]. It was founded by [[Ramdev|Baba Ramdev]] and [[Balkrishna|Acharya Balkrishna]] in 2006.<ref>{{Cite news|url=https://www.forbes.com/sites/meghabahree/2016/10/26/indias-baba-ramdev-billionaire-is-not-baba-ramdev/|title=India's Baba Ramdev Billionaire Is Not Baba Ramdev|last=Bahree|first=Megha|date=26 October 2016|newspaper=Forbes|access-date=16 February 2017}}</ref> Its registered office is located in [[Delhi]], with [[Manufacturing|manufacturing units]] and headquarters in the industrial area of [[Haridwar]].<ref>{{Cite news|url=http://www.thehindu.com/news/cities/Delhi/430-acres-allotted-to-Patanjali/article16984837.ece|title=430 acres allotted to Patanjali|last=Aradhak|first=Purusharth|work=The Hindu |language=en |access-date=26 February 2017}}</ref> The company manufactures cosmetics, ayurvedic medicine, and food products.<ref>{{Cite news|last=Worth|first=Robert F.|date=2018-07-26|title=The Billionaire Yogi Behind Modi’s Rise|language=en-US|work=The New York Times|url=https://www.nytimes.com/2018/07/26/magazine/the-billionaire-yogi-behind-modis-rise.html|access-date=2021-07-13|issn=0362-4331}}</ref>


== Description ==
'''Patanjali Ayurved''' is an Indian [[Conglomerate (company)|multinational conglomerate]] [[holding company]], based in [[Haridwar]]. It was founded by [[Ramdev]] and [[Balkrishna]] in 2006.<ref name="forbes">{{Cite news|url=https://www.forbes.com/sites/meghabahree/2016/10/26/indias-baba-ramdev-billionaire-is-not-baba-ramdev/|title=India's Baba Ramdev Billionaire Is Not Baba Ramdev|last=Bahree|first=Megha|date=26 October 2016|newspaper=Forbes|access-date=16 February 2017}}</ref> Its office is in [[Delhi]], with [[Manufacturing|manufacturing units]] and headquarters in the industrial area of Haridwar.<ref>{{Cite news|url=http://www.thehindu.com/news/cities/Delhi/430-acres-allotted-to-Patanjali/article16984837.ece|title=430 acres allotted to Patanjali|last=Aradhak|first=Purusharth|work=The Hindu|language=en|access-date=26 February 2017|archive-date=20 January 2023|archive-url=https://web.archive.org/web/20230120063126/https://www.thehindu.com/news/cities/Delhi/430-acres-allotted-to-Patanjali/article16984837.ece|url-status=live}}</ref> The company manufactures [[Cosmetics|cosmetic]]s, [[ayurvedic medicine]], [[personal care]] and [[food product]]s.<ref>{{Cite news|last=Worth|first=Robert F.|date=2018-07-26|title=The Billionaire Yogi Behind Modi's Rise|language=en-US|work=The New York Times|url=https://www.nytimes.com/2018/07/26/magazine/the-billionaire-yogi-behind-modis-rise.html|access-date=2021-07-13|issn=0362-4331|archive-date=5 June 2023|archive-url=https://web.archive.org/web/20230605231855/https://www.nytimes.com/2018/07/26/magazine/the-billionaire-yogi-behind-modis-rise.html|url-status=live}}</ref> The CEO of the company, with a 94-percent share hold, is Balkrishna. Ramdev represents the company and makes strategic decisions.<ref>{{citation |title=Baba Ramdev's Patanjali starts to take a toll on some FMCG firms |url=https://economictimes.indiatimes.com/industry/cons-products/fmcg/baba-ramdevs-patanjali-starts-to-take-a-toll-on-some-fmcg-firms/articleshow/51183398.cms |work=[[The Economic Times]] |date=29 February 2016 |last1=Vyas |first1=Jwalit }}</ref><ref name=":2">{{Cite web|date=4 May 2017|title=Baba Ramdev is just the face, it's Acharya Balakrishna who is behind Patanjali's Rs 10,561 cr turnover|url=https://www.businesstoday.in/current/corporate/baba-ramdev-acharya-balakrishna-patanjali-ayurveda-turnover/story/251462.html|url-status=live|archive-url=https://web.archive.org/web/20201003165215/https://www.businesstoday.in/current/corporate/baba-ramdev-acharya-balakrishna-patanjali-ayurveda-turnover/story/251462.html|archive-date=3 October 2020|access-date=30 May 2021|website=Business Today}}</ref><ref>{{Cite news|last1=Findlay|first1=Stephanie|last2=Singh|first2=Jyotsna|date=6 August 2020|title=India's yogi tycoon angers critics with coronavirus 'cure' kit|work=[[Financial Times]]|url=https://www.ft.com/content/f4a63ebf-5764-4570-9211-fd76b7e6c614}}</ref> The company has faced various controversies over its misleading promotions and false claims for COVID-19 treatment.<ref name="BBC Coronil"/>
The CEO of the company with 94% shareholding is Balkrishna, while Ramdev represents the company and makes strategic decisions.<ref>{{citation |title=Baba Ramdev's Patanjali starts to take a toll on some FMCG firms |url=http://economictimes.com/industry/cons-products/fmcg/baba-ramdevs-patanjali-starts-to-take-a-toll-on-some-fmcg-firms/articleshow/51183398.cms |work=[[The Economic Times]] |date=29 February 2016 }}</ref><ref name=":2">{{Cite web|date=4 May 2017|title=Baba Ramdev is just the face, it's Acharya Balakrishna who is behind Patanjali's Rs 10,561 cr turnover|url=https://www.businesstoday.in/current/corporate/baba-ramdev-acharya-balakrishna-patanjali-ayurveda-turnover/story/251462.html|url-status=live|archive-url=https://web.archive.org/web/20201003165215/https://www.businesstoday.in/current/corporate/baba-ramdev-acharya-balakrishna-patanjali-ayurveda-turnover/story/251462.html|archive-date=3 October 2020|access-date=30 May 2021|website=Business Today}}</ref> Products sold by the company range from [[hand sanitizer]], [[ghee]] and herbal [[toothpaste]], to [[ayurveda|ayurvedic]] products.<ref>{{Cite news|last1=Findlay|first1=Stephanie|last2=Singh|first2=Jyotsna|date=6 August 2020|title=India's yogi tycoon angers critics with coronavirus 'cure' kit|work=[[Financial Times]]|url=https://www.ft.com/content/f4a63ebf-5764-4570-9211-fd76b7e6c614}}</ref>


==History==
==History==
[[Ramdev]] established Patanjali [[Ayurveda|Ayurved]] Limited in 2007 along with [[Balkrishna]].<ref>{{cite news|url=http://www.huffingtonpost.in/2015/01/13/ramdev-consumer-products-_n_6460760.html|title=Baba Ramdev's Business Empire Soars, With His Own Rising Profile|publisher=HuffPost India}}</ref><ref>{{cite news|url=http://www.business-standard.com/article/management/the-patanjali-effect-116020800204_1.html |title=The Patanjali effect |last=Rakshit |first=Avishek |newspaper=Business-Standard |date=8 February 2016}}</ref> [[Balkrishna]] owns 94% of the company and the remaining is dispersed among other individuals.<ref name=":2" /> {{As of|2021|May}}, Balkrishna had a net worth of {{US$|2.3}} billion.<ref name="Forbes profile">{{cite web|title=Forbes profile: Acharya Balkrishna|url=https://www.forbes.com/profile/acharya-balkrishna/|url-status=live|access-date=30 May 2021|website=Forbes}}</ref>
[[Ramdev]] and [[Balkrishna]] established Patanjali Ayurved in 2006.<ref name="forbes" /><ref>{{cite news|url=http://www.huffingtonpost.in/2015/01/13/ramdev-consumer-products-_n_6460760.html|title=Baba Ramdev's Business Empire Soars, With His Own Rising Profile|publisher=HuffPost India|access-date=18 January 2015|archive-date=4 May 2015|archive-url=https://web.archive.org/web/20150504214640/http://www.huffingtonpost.in/2015/01/13/ramdev-consumer-products-_n_6460760.html|url-status=live}}</ref><ref>{{cite news|url=http://www.business-standard.com/article/management/the-patanjali-effect-116020800204_1.html |title=The Patanjali effect |last=Rakshit |first=Avishek |newspaper=Business-Standard |date=8 February 2016}}</ref> Balkrishna owns 94 percent of the company, and the remainder is dispersed among other individuals.<ref name=":2" /> In May 2021, Balkrishna had a net worth of {{US$|2.3}} billion.<ref name="Forbes profile">{{cite web|title=Forbes profile: Acharya Balkrishna|url=https://www.forbes.com/profile/acharya-balkrishna/|access-date=30 May 2021|website=Forbes}}</ref>
 
According to [[CLSA]] and [[HSBC]], Patanjali was one of the fastest-growing [[Fast-moving consumer goods|FMCG]] companies in India in 2016. It was valued at {{INRConvert|3000|c|link=yes|year=2016}}.<ref>{{Cite news|url=http://www.thehindubusinessline.com/companies/are-pes-bending-over-backwards-to-invest-in-patanjali/article8093259.ece|title=Are PEs bending over backwards to invest in Patanjali?|work=The Hindu|date=11 January 2016}}</ref><ref>{{Cite news|url=http://www.indiainfoline.com/article/news-top-story/india-consumer-patanjali-is-disrupting-india%E2%80%99s-consumer-space-116020600292_1.html|title=Patanjali is disrupting India's consumer space|publisher=IIFL|date=6 February 2016|access-date=7 February 2016|archive-date=17 May 2022|archive-url=https://web.archive.org/web/20220517204821/https://www.indiainfoline.com/article/news-top-story/india-consumer-patanjali-is-disrupting-india%E2%80%99s-consumer-space-116020600292_1.html|url-status=live}}</ref><ref name=ET_HSBC>{{Cite news|url=http://economictimes.indiatimes.com/markets/stocks/news/hsbc-global-rsearch-cuts-target-prices-of-britannia-dabur-and-nestle-between-6-and-16-says-patanjali/articleshow/50868122.cms|title=HSBC Global Rsearch{{sic|hide=y}} cuts target prices of Britannia Dabur and Nestle between 6% and 16%, says Patanjali|publisher=Economic Times|date=5 February 2016|access-date=7 February 2016|archive-date=23 May 2022|archive-url=https://web.archive.org/web/20220523034208/https://economictimes.indiatimes.com/markets/stocks/news/hsbc-global-rsearch-cuts-target-prices-of-britannia-dabur-and-nestle-between-6-and-16-says-patanjali/articleshow/50868122.cms|url-status=live}}</ref> Patanjali estimated its annual turnover for the 2016–17 fiscal year at {{INR Convert|10216|c}}.<ref>{{cite web|url=http://wap.business-standard.com/article-amp/markets/wap.business-standard.com/article/companies/ramdev-s-patanjali-doubles-sales-to-rs-10-561-crore-in-fy17-117050400652_1.html|title=Ramdev's Patanjali shakes up FMCG order; next up 'nutritious restaurants'|work=Business Standard|access-date=15 July 2017|archive-url=https://web.archive.org/web/20170715102827/http://wap.business-standard.com/article-amp/markets/wap.business-standard.com/article/companies/ramdev-s-patanjali-doubles-sales-to-rs-10-561-crore-in-fy17-117050400652_1.html|archive-date=15 July 2017|author=Arnab Dutta|date=5 May 2017}}</ref> According to a report by [[India Infoline]] (IIFL), at least 13 listed companies would be affected by Patanjali's success; they included [[Hindustan Unilever]], [[Colgate-Palmolive|Colgate]], [[Dabur]], [[ITC (company)|ITC]], and [[Godrej Consumer Products]].<ref name=ET_HSBC />
 
In 2025, Patanjali Ayurved along with [[DS Group]] acquired Magma General Insurance for ₹4,500 crore. <ref>{{cite web |title=Patanjali Ayurved, DS Group to acquire Magma General Insurance for ₹4,500 crore |url=https://www.thehindu.com/business/patanjali-ayurved-ds-group-to-acquire-magma-general-insurance-for-4500-crore/article69327031.ece |website=The Hindu |language=en-IN |date=13 March 2025}}</ref>


According to [[CLSA]] and [[HSBC]], Patanjali was the fastest growing [[Fast-moving consumer goods|FMCG]] company in [[India]] in 2016. It was valued at {{INRConvert|3000|c|lk=|year=2016}}.<ref>{{Cite news|url=http://www.thehindubusinessline.com/companies/are-pes-bending-over-backwards-to-invest-in-patanjali/article8093259.ece|title=Are PEs bending over backwards to invest in Patanjali?|work=The Hindu|date=11 January 2016}}</ref><ref>{{Cite news|url=http://www.indiainfoline.com/article/news-top-story/india-consumer-patanjali-is-disrupting-india%E2%80%99s-consumer-space-116020600292_1.html|title=Patanjali is disrupting India's consumer space|publisher=IIFL|date=6 February 2016}}</ref><ref name=ET_HSBC>{{Cite news|url=http://economictimes.indiatimes.com/markets/stocks/news/hsbc-global-rsearch-cuts-target-prices-of-britannia-dabur-and-nestle-between-6-and-16-says-patanjali/articleshow/50868122.cms|title=HSBC Global Rsearch{{sic|hide=y}} cuts target prices of Britannia Dabur and Nestle between 6% and 16%, says Patanjali|publisher=Economic Times|date=5 February 2016}}</ref> Patanjali declared its annual turnover of the year 2016–17 to be estimated at {{INR Convert|10216|c}}.<ref>{{cite web|url=http://wap.business-standard.com/article-amp/markets/wap.business-standard.com/article/companies/ramdev-s-patanjali-doubles-sales-to-rs-10-561-crore-in-fy17-117050400652_1.html|title=Ramdev's Patanjali shakes up FMCG order; next up 'nutritious restaurants'|work=Business Standard|access-date=15 July 2017|archive-url=https://web.archive.org/web/20170715102827/http://wap.business-standard.com/article-amp/markets/wap.business-standard.com/article/companies/ramdev-s-patanjali-doubles-sales-to-rs-10-561-crore-in-fy17-117050400652_1.html|archive-date=15 July 2017|author=Arnab Dutta|date=5 May 2017}}</ref> According to a report by [[India Infoline]] (IIFL), at least 13 listed companies would be affected by Patanjali's success including [[Colgate-Palmolive|Colgate]], [[Dabur]], [[ITC (company)|ITC]], and [[Godrej Consumer Products Limited|Godrej Consumer]].<ref name=ET_HSBC />
In December 2025, The [[Government of Tripura]] partnered with Patanjali Ayurved for a project in [[Tripura State]] worth Rs 300-400 crores.<ref>{{cite web |title=Tripura government sign MOU with Patanjali Ayurved for project in Tripura |url=https://tripurainfo.com/EnglishNews.aspx?intnid=4370&title=Tripura-government-sign-MOU-with-Patanjali-Ayurved-for-project-in-Tripura |website=tripurainfo DOT com |language=en}}</ref>


==Revenues==
Patanjali Ayurved opened a hospital "Patanjali Emergency & Critical Care Hospital" on 22nd January 2026 which was inaugurated by home minister of India [[Amit Shah]].<ref>{{cite web |title=Patanjali launches India’s first hybrid hospital for heart, brain and spine care |url=https://timesofindia.indiatimes.com/life-style/health-plus/patanjali-launches-indias-first-hybrid-hospital-for-heart-brain-and-spine-care/articleshow/127151631.cms |website=The Times of India |date=22 January 2026}}</ref>
 
=={{anchor|Revenues}}Revenue==
{| class="wikitable"
{| class="wikitable"
|-
|-
! Year !! Revenues
! Year !! Revenue
([[Indian rupee sign|₹]] in [[Crore|Crores]])
in crores
|-
|-
| 2010-11 || 100
| 2010–11 || ₹1000
|-
|-
| 2011-12 || 300
| 2011–12 || ₹300
|-
|-
| 2012-13 || 841
| 2012–13 || ₹841
|-
|-
| 2013-14 || 1,184
| 2013–14 || ₹1,184
|-
|-
| 2014-15 || 2,006
| 2014–15 || ₹2,006
|-
|-
| 2015-16 || 8,000
| 2015–16 || ₹8,000


|-
|-
| 2016-17 || 10,526 <ref name=lm0518>{{citation |title=Patanjali sales growth grinds to a halt in FY18 |url=https://www.livemint.com/Companies/ZLN3sCZjnx49GSo1jAma9H/Patanjali-sales-growth-grinds-to-a-halt-in-FY18.html |work=[[Livemint]] |date=18 May 2018 }}</ref>
| 2016–17 || ₹10,526<ref name=lm0518>{{citation |title=Patanjali sales growth grinds to a halt in FY18 |url=https://www.livemint.com/Companies/ZLN3sCZjnx49GSo1jAma9H/Patanjali-sales-growth-grinds-to-a-halt-in-FY18.html |work=[[Livemint]] |date=18 May 2018 }}</ref>
|-
|-
| 2017-18 ||9,500 <ref name=bs0517>{{citation |title=Patanjali and its grand plans: Ramdev expects Rs 20,000 cr revenue in FY18 |url=http://wap.business-standard.com/article/companies/patanjali-and-its-grand-plans-ramdev-expects-rs-20-000-cr-revenue-in-fy18-117050400474_1.html |work=[[Business Standard]] |date=4 May 2017 }}</ref>
| 2017–18 ||₹9,500<ref name=bs0517>{{citation |title=Patanjali and its grand plans: Ramdev expects Rs 20,000 cr revenue in FY18 |url=http://wap.business-standard.com/article/companies/patanjali-and-its-grand-plans-ramdev-expects-rs-20-000-cr-revenue-in-fy18-117050400474_1.html |work=[[Business Standard]] |date=4 May 2017 |agency=Press Trust of India }}</ref>
|-
|-
| 2018-19 ||8,330 <ref name=bt0516>{{citation |title=Patanjali reports Rs 8,339 crore revenue in FY 19; food items account for 62% of total sales |url=http://www.businesstoday.in/current/corporate/patanjali-reports-rs-8330-crore-fy-19-food-items-account-62-per-cent-of-total-sales/story/390613.html |work=[[Business Today (India)|Business Today]] |date=19 November 2019 }}</ref>
| 2018–19 ||₹8,330<ref name=bt0516>{{citation |title=Patanjali reports Rs 8,339 crore revenue in FY 19; food items account for 62% of total sales |url=http://www.businesstoday.in/current/corporate/patanjali-reports-rs-8330-crore-fy-19-food-items-account-62-per-cent-of-total-sales/story/390613.html |work=[[Business Today (India)|Business Today]] |date=19 November 2019 |access-date=20 December 2019 |archive-date=15 January 2024 |archive-url=https://web.archive.org/web/20240115060434/https://www.businesstoday.in/latest/corporate/story/patanjali-reports-rs-8330-crore-fy-19-food-items-account-62-per-cent-of-total-sales-238712-2019-11-19 |url-status=live }}</ref>
|-
|-
|2019-20
|9,022
|}
|}
[[Future Group]], which has tied up with Patanjali sells about {{INRConvert|30|c}} worth of Patanjali products every month.<ref>{{Cite news|url=http://www.ibtimes.co.in/baba-ramdevs-patanjali-group-compels-fmcg-firms-hindustan-unilever-dabur-expand-portfolio-664429|title=Baba Ramdev's Patanjali Group compels FMCG firms Hindustan Unilever and Dabur to expand portfolio|publisher=IBT times|date=26 January 2016}}</ref><ref>http://www.india.com/news/india/patanjali-ayurved-doubles-its-profit-in-one-year-set-to-catch-up-with-rivals-1051546/ Patanjali Ayurved doubles its profit in one year; set to catch up with rivals</ref><ref>{{cite news|title=Inside Baba Ramdev's Patanjali empire|url=http://www.livemint.com/Companies/hLEBBx17cFY5rPjTjmIP9O/The-Patanjali-story.html}}</ref>
[[Future Group]], which has joined with Patanjali, sells about {{INRConvert|30|c}} worth of Patanjali products every month.<ref>{{Cite news|url=http://www.ibtimes.co.in/baba-ramdevs-patanjali-group-compels-fmcg-firms-hindustan-unilever-dabur-expand-portfolio-664429|title=Baba Ramdev's Patanjali Group compels FMCG firms Hindustan Unilever and Dabur to expand portfolio|work=IBT Times|date=26 January 2016|access-date=7 February 2016|archive-date=15 January 2024|archive-url=https://web.archive.org/web/20240115060400/https://www.ibtimes.co.in/baba-ramdevs-patanjali-group-compels-fmcg-firms-hindustan-unilever-dabur-expand-portfolio-664429|url-status=live}}</ref><ref>http://www.india.com/news/india/patanjali-ayurved-doubles-its-profit-in-one-year-set-to-catch-up-with-rivals-1051546/ {{Webarchive|url=https://web.archive.org/web/20240115060433/https://www.india.com/news/india/patanjali-ayurved-doubles-its-profit-in-one-year-set-to-catch-up-with-rivals-1051546/ |date=15 January 2024 }} Patanjali Ayurved doubles its profit in one year; set to catch up with rivals</ref><ref>{{Cite web|url=https://www.livemint.com/Companies/hLEBBx17cFY5rPjTjmIP9O/The-Patanjali-story.html|title=Inside Baba Ramdev's Patanjali empire|first=Sounak|last=Mitra|date=3 June 2016|website=[[Mint (newspaper)|livemint]]|access-date=18 December 2022|archive-date=15 January 2024|archive-url=https://web.archive.org/web/20240115060445/https://www.livemint.com/Companies/hLEBBx17cFY5rPjTjmIP9O/The-Patanjali-story.html|url-status=live}}</ref>


==Production==
==Production==
Patanjali Food and Herbal Park at [[Haridwar]] is the main production facility operated by Patanjali Ayurved. The company has a production capacity of {{INRConvert|35000|c|lk=|year=2018}} and is in the process of expanding to a capacity of {{INRConvert|60000|c|lk=|year=2016}} through its new production units at several places, including [[Noida]], [[Nagpur]], and [[Indore]].<ref name=bs0517/><ref>{{cite news|publisher=Web Dunia|url=http://hindi.webdunia.com/international-hindi-news/baba-ramdev-herbal-factory-herbal-products-nepal-kathmandu-115041800030_1.html|title=Ramdev to open herbal factory in Nepal|date=18 April 2015}}</ref><ref>{{cite news|url=http://insighttvnews.com/newsdetails.php?show=83816|title=Patanjali herbal park in Nepal|publisher=Insight TV News Network|date=28 February 2015}}</ref>
Patanjali Food and Herbal Park in [[Haridwar]] is the company's main production facility. With a production capacity of {{INRConvert|35000|c|lk=|year=2018}}, it is expanding to a capacity of {{INRConvert|60000|c|lk=|year=2016}} through new production units in [[Noida]], [[Nagpur]], and [[Indore]].<ref name=bs0517/><ref>{{cite news|publisher=Web Dunia|url=http://hindi.webdunia.com/international-hindi-news/baba-ramdev-herbal-factory-herbal-products-nepal-kathmandu-115041800030_1.html|title=Ramdev to open herbal factory in Nepal|date=18 April 2015}}</ref><ref>{{cite news|url=http://insighttvnews.com/newsdetails.php?show=83816|title=Patanjali herbal park in Nepal|publisher=Insight TV News Network|date=28 February 2015|access-date=29 October 2015|archive-date=2 April 2015|archive-url=https://web.archive.org/web/20150402155901/http://insighttvnews.com/newsdetails.php?show=83816|url-status=live}}</ref>


In 2016, the Patanjali Food and Herbal Park were given a full-time security cover of 35 armed [[Central Industrial Security Force]] (CISF) commandos.<ref>{{cite web|url=http://www.newindianexpress.com/nation/CISF-Team-to-Guard-Ramdevs-Food-Park/2016/03/09/article3317272.ece|title=CISF Team to Guard Ramdev's Food Park|place=NEW DELHI|first=Yatish|last=Yadav |date=9 March 2016 |publisher=Indian Express}}</ref><ref>{{cite web|url=http://www.ndtv.com/india-news/ramdev-now-a-client-of-paramilitary-force-cisf-for-his-food-park-1285079|title=Ramdev's Food Park Gets Round-The-Clock Protection From Paramilitary CISF|first=Varun|last=Sharma |date=8 March 2016 |publisher=NDTV}}</ref><ref name="Tribune_India">{{cite web|url=http://www.tribuneindia.com/news/uttarakhand/ramdev-s-food-park-gets-full-time-cisf-cover/206339.html|title=Ramdev's food park gets full-time CISF cover |date=9 March 2016 |publisher=The Tribune India}}</ref> The park will be the eighth private institute in [[India]] to be guarded by [[Central Industrial Security Force|CISF]] paramilitary forces.<ref name="Tribune_India"/> [[Ramdev]] himself is a "Z" category protectee of central paramilitary forces.<ref name="Tribune_India"/>
In 2016, the Patanjali Food and Herbal Park received 35 full-time, armed [[Central Industrial Security Force]] (CISF) commandos.<ref>{{cite web|url=http://www.newindianexpress.com/nation/CISF-Team-to-Guard-Ramdevs-Food-Park/2016/03/09/article3317272.ece|archive-url=https://web.archive.org/web/20160309150415/http://www.newindianexpress.com/nation/CISF-Team-to-Guard-Ramdevs-Food-Park/2016/03/09/article3317272.ece|url-status=dead|archive-date=9 March 2016|title=CISF Team to Guard Ramdev's Food Park|place=NEW DELHI|first=Yatish|last=Yadav |date=9 March 2016 |publisher=Indian Express}}</ref><ref>{{cite web|url=http://www.ndtv.com/india-news/ramdev-now-a-client-of-paramilitary-force-cisf-for-his-food-park-1285079|title=Ramdev's Food Park Gets Round-The-Clock Protection From Paramilitary CISF|first=Varun|last=Sharma|date=8 March 2016|publisher=NDTV|access-date=9 March 2016|archive-date=15 January 2024|archive-url=https://web.archive.org/web/20240115060431/https://www.ndtv.com/india-news/ramdev-now-a-client-of-paramilitary-force-cisf-for-his-food-park-1285079|url-status=live}}</ref><ref name="Tribune_India">{{cite web|url=http://www.tribuneindia.com/news/uttarakhand/ramdev-s-food-park-gets-full-time-cisf-cover/206339.html|title=Ramdev's food park gets full-time CISF cover|date=9 March 2016|publisher=The Tribune India}}{{Dead link|date=August 2025 |bot=InternetArchiveBot |fix-attempted=yes }}</ref> The park will be the eighth private institute in India to be guarded by [[paramilitary]] CISF forces.<ref name="Tribune_India"/>


In 2017, the Patanjali group launched their official Caller Tune with their slogan '[[Swadeshi movement|Swadeshi]] Swabhiman, Rashtra Seva Ka Abhiyan' music composed by Vaibhav Saxena.<ref>{{cite web|url=https://www.dailypioneer.com/2017/state-editions/swadeshi-ringtone-patanjali-aims-to-stretch-its-outreach.html|title=Swadeshi ringtone: Patanjali aims to stretch its outreach |date=30 August 2017 |publisher=The Pioneer}}</ref>
=={{anchor|Controversies}}Controversies==
Patanjali Ayurved has had many cases filed against by the [[Government of Uttarakhand]] for various offences<ref>{{cite news |last1=Prashant |first1=Shishir |title=With BJP in power, focus is now on cases against Baba Ramdev |url=https://www.business-standard.com/article/current-affairs/with-bjp-in-power-focus-is-now-on-cases-against-baba-ramdev-117032000860_1.html |access-date=21 December 2020 |work=Business Standard India |date=20 March 2017}}</ref>


==Controversies==
In June 2025, [[Uttarakhand High Court|The Nainital High Court]] has quashed the criminal case against Patanjali Ayurveda Limited and its founders [[Ramdev|Baba Ramdev]] and [[Acharya Balkrishna]] for publishing misleading advertisements.<ref>{{cite web |title=Uttarakhand News: पतंजलि, बाबा रामदेव और आचार्य बालकृष्ण के खिलाफ आपराधिक मामला रद्द, जानिये मामला |url=https://www.amarujala.com/uttarakhand/nainital/uttarakhand-news-criminal-case-against-patanjali-baba-ramdev-and-acharya-balkrishna-quashed-2025-06-26 |website=Amar Ujala |language=hi}}</ref>
Ramdev has had approximately 100 cases filed against him by the [[Government of Uttarakhand]], citing various offences.<ref>{{cite news |last1=Prashant |first1=Shishir |title=With BJP in power, focus is now on cases against Baba Ramdev |url=https://www.business-standard.com/article/current-affairs/with-bjp-in-power-focus-is-now-on-cases-against-baba-ramdev-117032000860_1.html |access-date=21 December 2020 |work=Business Standard India |date=20 March 2017}}</ref> Among these, 81 cases against the Patanjali Yog Peeth and its sister concerns in Haridwar were registered for violations of the Zamindari Abolition and  [[Land reform in India|Land Reforms]] (ZALR) Act and the Indian Stamps Act.<ref name="HT 81">{{cite news |title=81 cases filed against Ramdev |url=https://www.thehindu.com/news/national/other-states/81-cases-filed-against-ramdev/article5372104.ece |access-date=21 December 2020 |work=The Hindu |date=20 November 2013 |language=en-IN}}</ref>


The company has been accused of misleading advertisements<ref>{{Cite web|title=Patanjali Advertisements Unsubstantiated, Misleading: Watchdog|url=https://www.ndtv.com/business/patanjali-advertisements-unsubstantiated-misleading-says-watchdog-1427896|access-date=2021-05-02|website=NDTV.com}}</ref><ref>{{Cite web|title=Patanjali Ayurved Rapped For Misleading Hair Oil, Other Advertisements|url=https://www.ndtv.com/business/patanjali-ayurved-rapped-for-misleading-hair-oil-other-advertisements-1412436|access-date=2021-05-02|website=NDTV.com}}</ref> about its products and flimsy testing before being launched to market.<ref>{{Cite web|date=2017-05-29|title=Ramdev's Patanjali products fail quality test, RTI inquiry finds|url=https://www.hindustantimes.com/india-news/baba-ramdev-s-patanjali-products-fail-uttarakhand-quality-test/story-bXo4XySEajw7ZDby4GISML.html|access-date=2020-10-07|website=Hindustan Times|language=en}}</ref> Between April 2015 and July 2016, 33 complaints were received against 21 misleading advertisements, 17 of which were found to violate [[Advertising Standards Council of India|ASCI]] standards.<ref>{{Cite web|title=33 Complaints Received Against Patanjali Advertisements|url=https://www.ndtv.com/business/33-complaints-received-against-patanjali-advertisements-1439145|access-date=2021-05-02|website=NDTV.com}}</ref> In September 2017, the [[Delhi High Court]] has ordered the company to stop airing an advertisement that promotes its brand of [[Chyavanprash]] that disparaged a competitor's.<ref>{{Cite web|date=7 September 2017|title=Delhi Court Restrains Patanjali From Airing Ads Promoting Chyawanprash|url=https://www.ndtv.com/india-news/delhi-court-restrains-patanjali-from-airing-ads-promoting-chyawanprash-1747432|url-status=live|archive-url=https://web.archive.org/web/20170911112632/https://www.ndtv.com/india-news/delhi-court-restrains-patanjali-from-airing-ads-promoting-chyawanprash-1747432|archive-date=2017-09-11|access-date=2021-05-02|website=NDTV.com}}</ref> Some products such as amla juice<ref>{{Cite web|last=Dangwal|first=Sandhya|date=2017-04-24|title=CSD withdraws Baba Ramdev's popular product after lab declares it unfit for consumption|url=https://www.india.com/business/patanjali-amla-juice-banned-csd-withdraws-baba-ramdevs-popular-product-after-lab-declares-it-unfit-for-consumption-2062146/|access-date=2020-10-07|website=India News, Breaking News, Entertainment News {{!}} India.com|language=en}}</ref><ref name="sayingtruth.com">{{Cite web|date=2017-04-24|title=Military Canteens Ban sales of Patanjali Amla Juice|url=https://www.sayingtruth.com/patanjali-amla-juice-banned/|access-date=2020-10-07|website=Saying Truth|language=en-US}}</ref> and [[ayurvedic medicine]]s<ref>{{Cite web|date=2017-06-22|title=Nepal drug administration reject six Patanjali products after tests, contain pathogenic bacteria - India News, Firstpost|url=https://www.firstpost.com/india/nepal-drug-administration-reject-six-patanjali-products-after-tests-contain-pathogenic-bacteria-3735231.html|access-date=2020-10-07|website=Firstpost}}</ref> have been banned from sales due to their poor quality. Patanjali has also been surrounded by controversies regarding the working conditions where Ramdev and Acharya Balkrishna are treated as gurus, whose feet must be touched each time they enter an area. Workers are paid a salary of {{INRConvert|6000}} per month while working 12-hour shifts 6 days a week.<ref name="sayingtruth.com"/> They are also discouraged to ask for a raise as working at a factory is considered "seva" (service) to the cause.<ref>{{Cite web|last=Pathak-Narain|first=Priyanka|date=2017-08-04|title=Patanjali believes its staff does 'seva': Ex-CEO S.K. Patra|url=https://www.livemint.com/Companies/WuAWfDBchBSJcR6ERuvI8M/Patanjali-Ayurved-believes-its-staff-does-seva-ExCEO-SK.html|access-date=2021-05-10|website=mint|language=en}}</ref>
Patanjali has been cited for its working conditions; Ramdev and Balkrishna are treated as gurus whose feet must be touched each time they enter an area. Workers are paid {{INRConvert|6000}} per month, working 12-hour shifts, six days a week.<ref name="sayingtruth.com" /><ref name=":17"/> They are also discouraged from asking for a raise, with the rationale that working at the factory is considered "seva" (voluntary service) to the cause and is a payment in itself.<ref name=":17">{{Cite news |title=Baba Ramdev: Inside Patanjali: Here's what life is like in Baba Ramdev's company |work=The Economic Times |url=https://economictimes.indiatimes.com/industry/cons-products/fmcg/inside-patanjali-heres-what-life-is-like-in-baba-ramdevs-company/articleshow/59824892.cms |access-date=2022-10-10 |archive-date=15 January 2024 |archive-url=https://web.archive.org/web/20240115061944/https://economictimes.indiatimes.com/industry/cons-products/fmcg/inside-patanjali-heres-what-life-is-like-in-baba-ramdevs-company/articleshow/59824892.cms |url-status=live }}</ref><ref>{{Cite web|last=Pathak-Narain|first=Priyanka|date=2017-08-04|title=Patanjali believes its staff does 'seva': Ex-CEO S.K. Patra|url=https://www.livemint.com/Companies/WuAWfDBchBSJcR6ERuvI8M/Patanjali-Ayurved-believes-its-staff-does-seva-ExCEO-SK.html|access-date=2021-05-10|website=mint|language=en|archive-date=15 January 2024|archive-url=https://web.archive.org/web/20240115062022/https://www.livemint.com/Companies/WuAWfDBchBSJcR6ERuvI8M/Patanjali-Ayurved-believes-its-staff-does-seva-ExCEO-SK.html|url-status=live}}</ref><ref>{{cite news |author=<!--Staff writer(s)/no by-line.--> |title=Baba Ramdev wants employees to work for free: A former CEO reveals the Patanjali story |url=https://www.newindianexpress.com/business/2017/aug/04/baba-ramdev-wants-employees-to-work-for-free-a-former-ceo-reveals-the-patanjali-story-1638376.html |work=The New Indian Express (newspaper) |date=4 August 2017 |archive-url=https://web.archive.org/web/20210418135632/https://www.newindianexpress.com/business/2017/aug/04/baba-ramdev-wants-employees-to-work-for-free-a-former-ceo-reveals-the-patanjali-story-1638376.html |archive-date=18 April 2021}}</ref> On 22 May 2021, the [[Indian Medical Association]] (IMA) in Uttarakhand sent a defamation notice of {{INRConvert|1000|c|year=2021}} after remarks by Ramdev about doctors who practise [[evidence-based medicine]].<ref>{{Cite web|date=2021-05-26|title='Criminal act': Ramdev gets ₹1,000 cr defamation notice from IMA Uttarakhand|url=https://www.hindustantimes.com/india-news/criminal-act-ramdev-gets-rs-1-000-cr-defamation-notice-from-ima-uttarakhand-101622014713092.html|access-date=2021-05-26|website=Hindustan Times|language=en|archive-date=15 January 2024|archive-url=https://web.archive.org/web/20240115061935/https://www.hindustantimes.com/india-news/criminal-act-ramdev-gets-rs-1-000-cr-defamation-notice-from-ima-uttarakhand-101622014713092.html|url-status=live}}</ref><ref>{{Cite web|title=IMA Uttarakhand sends Rs 1,000-cr defamation notice to Ramdev over remarks on allopathy|url=https://www.businesstoday.in/current/economy-politics/ima-uttarakhand-sends-rs-1000-cr-defamation-notice-to-ramdev-over-remarks-on-allopathy/story/440033.html|access-date=2021-05-26|website=www.businesstoday.in|date=26 May 2021 |archive-date=15 January 2024|archive-url=https://web.archive.org/web/20240115062031/https://www.businesstoday.in/latest/economy-politics/story/ima-uttarakhand-sends-rs-1000-cr-defamation-notice-to-ramdev-over-remarks-on-allopathy-297065-2021-05-26|url-status=live}}</ref>


On 22 May 2021, the [[Indian Medical Association]] (IMA) in Uttarakhand sent a defamation notice of {{INRConvert|1000|c|year=2021}} following a number of remarks made by Ramdev regarding doctors practising [[allopathic medicine]].<ref>{{Cite web|date=2021-05-26|title='Criminal act': Ramdev gets ₹1,000 cr defamation notice from IMA Uttarakhand|url=https://www.hindustantimes.com/india-news/criminal-act-ramdev-gets-rs-1-000-cr-defamation-notice-from-ima-uttarakhand-101622014713092.html|access-date=2021-05-26|website=Hindustan Times|language=en}}</ref><ref>{{Cite web|title=IMA Uttarakhand sends Rs 1,000-cr defamation notice to Ramdev over remarks on allopathy|url=https://www.businesstoday.in/current/economy-politics/ima-uttarakhand-sends-rs-1000-cr-defamation-notice-to-ramdev-over-remarks-on-allopathy/story/440033.html|access-date=2021-05-26|website=www.businesstoday.in}}</ref>
===Infertility cure===
One of the products manufactured by Ramdev's Divya pharmacy and sold by the Patanjali Pharmacy chain was Divya Putrajeevak Seed, described in its catalog as a natural herb which (according to the company) could treat infertility. However, doctors pointed out the misleading name of the drug: the word ''"putrajeevak"'' ({{translation|literal=yes}} "son's life" ). Some Patanjali Pharmacy stores sold the drug with the claim that it would ensure the birth of a boy, reportedly leading to an increase in sales.<ref name="Infertility">{{cite news |title=In Name of Ramdev's Infertility Cure, the Promise of a Boy Child? |url=https://www.ndtv.com/india-news/in-name-of-ramdevs-infertility-cure-the-promise-of-a-boy-child-735287 |access-date=21 December 2020 |work=NDTV.com}}</ref>


=== "Infertility cure" ===
The issue was raised in the [[Indian Parliament]] in July 2015 by opposition members who accused Ramdev of "peddling a product which promised delivery of male children." The Ministry of AYUSH (which oversees the sale of alternative medicines) defended the product's name, saying that it was named after a herb.<ref name="Infertility_BSI">{{cite news |title=Ramdev's 'Putrajeevak beej' is named after herb: AYUSH minister |url=https://www.business-standard.com/article/news-ians/ramdev-s-putrajeevak-beej-is-named-after-herb-ayush-minister-115052600772_1.html |access-date=21 December 2020 |work=Business Standard India |date=26 May 2015}}</ref>
One of the products manufactured by Ramdev's Divya pharmacy and sold by Patanjali Pharmacy chain was named "Divya Putrajeevak Seed" and was described in the catalog as a natural herb which, according to the company, could treat infertility. Doctors pointed out the misleading name of the drug as the word "''Putrajeevak''" in Hindi means "son's life." Some Patanjali Pharmacy stores sold the drug claiming that it would ensure the birth of a boy, which reportedly led to a rise in the sale of the drug among people who wished to have a son.<ref name="Infertility">{{cite news |title=In Name of Ramdev's Infertility Cure, the Promise of a Boy Child? |url=https://www.ndtv.com/india-news/in-name-of-ramdevs-infertility-cure-the-promise-of-a-boy-child-735287 |access-date=21 December 2020 |work=NDTV.com}}</ref>


In July 2015, the issue was raised in the [[Indian Parliament]] by members of the Opposition party who accused Ramdev of "peddling a product which promised delivery of male children." However, the Ministry of AYUSH, which oversees the sale of alternative medicines, defended the product's name, saying the medicine was named after a herb.<ref name="Infertility_BSI">{{cite news |title=Ramdev's 'Putrajeevak beej' is named after herb: AYUSH minister |url=https://www.business-standard.com/article/news-ians/ramdev-s-putrajeevak-beej-is-named-after-herb-ayush-minister-115052600772_1.html |access-date=21 December 2020 |work=Business Standard India |date=26 May 2015}}</ref>
In 2016, the Uttarakhand health department said that the drug violated the [[Pre-Conception and Pre-Natal Diagnostic Techniques Act, 1994]].<ref>{{cite news |last1=Azad |first1=Shivani |title=U'khand says Ramdev's fertility pill 'Putrajeevak Beej' violates PNDT Act |url=https://timesofindia.indiatimes.com/city/dehradun/Ukhand-says-Ramdevs-fertility-pill-Putrajeevak-Beej-violates-PNDT-Act/articleshow/50811703.cms |access-date=21 December 2020 |work=The Times of India |agency=TNN |date=2 February 2018 |language=en}}</ref> The Maharashtra government ordered a probe of whether the drug had violated laws in 2018, and Congress leaders in the state demanded a ban on the drug.<ref name="Infertility_MM">{{cite news |last1=Naik |first1=Yogesh |title=Govt to probe sale of controversial Patanjali product |url=https://mumbaimirror.indiatimes.com/mumbai/other/govt-to-probe-sale-of-controversial-patanjali-product/articleshow/65076799.cms |access-date=21 December 2020 |work=Mumbai Mirror |date=21 July 2018 |language=en}}</ref>


In 2016, the Uttarakhand health department said that the drug by Patanjali Ayurveda violated the Indian law, [[Pre-Conception and Pre-Natal Diagnostic Techniques Act, 1994|Pre-Conception, and Pre-Natal Diagnostic Techniques Act, 1994]].<ref>{{cite news |last1=Azad |first1=Shivani |title=U'khand says Ramdev's fertility pill 'Putrajeevak Beej' violates PNDT Act |url=https://timesofindia.indiatimes.com/city/dehradun/Ukhand-says-Ramdevs-fertility-pill-Putrajeevak-Beej-violates-PNDT-Act/articleshow/50811703.cms |access-date=21 December 2020 |work=The Times of India |agency=TNN |date=2 February 2018 |language=en}}</ref> In 2018, the Maharashtra government ordered a probe on the drug over charges that it violated laws. Congress leaders in the state demanded a ban on the drug.<ref name="Infertility_MM">{{cite news |last1=Naik |first1=Yogesh |title=Govt to probe sale of controversial Patanjali product |url=https://mumbaimirror.indiatimes.com/mumbai/other/govt-to-probe-sale-of-controversial-patanjali-product/articleshow/65076799.cms |access-date=21 December 2020 |work=Mumbai Mirror |date=21 July 2018 |language=en}}</ref>
==={{anchor|Ban Ganga river pollution}}Ganges pollution===
In January 2018, villages in [[Haridwar district]] complained that Patanjali's Padarth factory was polluting a [[Ganges]] channel and other local rain-fed bodies of water with [[surface runoff]]; chemicals released by the factory reportedly killed several animals in the area. The local government took no action on the factory due to Ramdev's influence, and residents of 40 villages threatened agitation.<ref name=HT_Ban_Ganga /> The Uttarakhand Environment Conservation and Pollution Control Board ordered a clean-up of the waste flowing through the area. In the past, the board had notified Padarth about its release of untreated industrial effluent into local bodies of water. Patanjali's general manager denied the allegations, saying that the company followed established protocols.<ref name=HT_Ban_Ganga>{{cite news |title=Villagers say Patanjali unit polluting water bodies in Haridwar |url=https://www.hindustantimes.com/dehradun/villagers-say-patanjali-unit-polluting-water-bodies-in-haridwar/story-3DQcv6z2jzoRyUzIrfXZlJ.html |access-date=21 December 2020 |work=Hindustan Times |date=23 January 2018 |language=en}}</ref>


===Ban Ganga river pollution ===
==={{anchor|Suspension of Amla juice}}Amla juice===
In January 2018, villages in Haridwar district complained that one of the Patanjali's factories named Padarth was polluting Ban [[Ganges|Ganga]] rivulet and a few other rain-fed water bodies in the locality by releasing effluents. According to the locals, the chemicals released by the factory had caused the death of several animals in the area over the years. The villagers had complained, but the local government took no action on the factory due to the influence of Ramdev. Residents of 40 villages had threatened agitations due to the inaction of the local bodies in taking action against pollution.<ref name=HT_Ban_Ganga /> Uttarakhand Environment Conservation and Pollution Control Board directed a clean-up of the Begum nullah flowing through the area. In the past, the board had served a notice to Padartha over the release of untreated industrial effluents into local water bodies. Patanjali's General Manager denied the allegations and claimed that it followed the protocols.<ref name=HT_Ban_Ganga>{{cite news |title=Villagers say Patanjali unit polluting water bodies in Haridwar |url=https://www.hindustantimes.com/dehradun/villagers-say-patanjali-unit-polluting-water-bodies-in-haridwar/story-3DQcv6z2jzoRyUzIrfXZlJ.html |access-date=21 December 2020 |work=Hindustan Times |date=23 January 2018 |language=en}}</ref>
The Ministry of Defence canteen stores department (CSD) suspended Patanjali Ayurved's amla juice after receiving an adverse state laboratory test report on the product; the central food laboratory found the juice unfit for consumption. The CSD asked its depots to make [[debit note]]s for their existing stock, so the product could be returned.<ref name="CSD withdraws"/><ref name="sayingtruth.com" /><ref name="Quality test and RTI inquiry"/><ref>{{cite news |url=https://www.businesstoday.in/lite/story/defence-canteens-remove-ramdevs-patanjali-amla-juice-after-adverse-lab-test-report/1/250631.html |title=Defence canteens remove Ramdev's Patanjali amla juice after adverse lab report |access-date=18 May 2020 |archive-date=15 January 2024 |archive-url=https://web.archive.org/web/20240115062629/https://www.businesstoday.in/amp/latest/economy-politics/story/defence-canteens-remove-ramdevs-patanjali-amla-juice-after-adverse-lab-test-report-79796-2017-04-24 |url-status=live }}</ref>


===Suspension of Amla juice===
==={{anchor|Notice by FSSAI}}FSSAI notices===
The Ministry of Defence canteen stores department (CSD) has suspended Patanjali Ayurved's amla juice after receiving an adverse state-laboratory test report on the product.
Patanjali introduced its [[instant noodles]] on 15 November 2015.<ref>{{cite news|url=http://www.thehindu.com/business/ramdevs-patanjali-launches-noodles/article7884161.ece|title=Ramdev's Patanjali launches noodles|work=The Hindu|date=16 November 2015|access-date=19 November 2015|archive-date=15 January 2024|archive-url=https://web.archive.org/web/20240115062514/https://www.thehindu.com/business/Ramdev%E2%80%99s-Patanjali-launches-noodles/article60235865.ece|url-status=live}}</ref><ref>{{cite web|url=http://khabar.ibnlive.com/news/desh/baba-ramdev-maggie-fssai-notice-patanjali-428194.html|title=FSSAI sends notice to Baba Ramdev's company|work=ibnlive.com|date=21 November 2015}}</ref><ref>{{cite news|url=http://navbharattimes.indiatimes.com/business/business-news/trouble-mounts-for-ramdevs-atta-noodles-fssai-issues-notice-to-patanjali-ayurved/articleshow/49870608.cms|title=Trouble mounts for Ramdev's Atta Noodles, FSSAI issues notice to Patanjali Ayurved|publisher=Navbharat Times}}</ref> The [[Food Safety and Standards Authority of India]] notified the company that neither Patanjali nor Aayush, the brand names for which Patanjali obtained licenses, received approval for the manufacture of instant noodles.<ref>{{cite news|url=http://www.ndtv.com/india-news/no-approval-for-patanjali-instant-noodles-says-food-safety-regulator-1244771|title=No Approval for Patanjali Instant Noodles, Says Food Safety Regulator|publisher=NDTV|date=18 November 2015}}</ref><ref>{{cite news|url=http://indianexpress.com/article/india/india-news-india/no-licence-for-noodles-fssai-slaps-showcause-on-patanjali/|title='No licence for noodles': FSSAI slaps showcause on Patanjali|date=21 November 2015|work=The Indian Express}}</ref><ref>{{cite news|url=http://www.oneindia.com/india/patanjali-s-atta-noodles-in-trouble-baba-ramdev-breaks-silence-modi-govt-controversy-1931379.html|title=Patanjali's Atta Noodles in trouble: Baba Ramdev breaks silence, drags Modi govt into controversy|publisher=oneindia.com|date=19 November 2015}}</ref><ref>{{cite news|url=http://www.livehindustan.com/news/national/article1-will-reply-at-the-earliest-when-we-get-notice-baba-ramdev-505128.html|title=Patanjali Atta noodles gets notice|publisher=livehindustan.com|access-date=13 January 2016|archive-date=26 November 2015|archive-url=https://web.archive.org/web/20151126174225/http://www.livehindustan.com/news/national/article1-will-reply-at-the-earliest-when-we-get-notice-baba-ramdev-505128.html|url-status=live}}</ref> In [[Rajasthan]], [[mustard oil]] sold by Patanjali was found substandard by the FSSAI's [[Alwar]] laboratory.<ref>{{Cite magazine|author=Sharat Kumar|date=June 10, 2021|title=Patanjali mustard oil found to be of substandard food quality: Rajasthan govt|url=https://www.indiatoday.in/india/rajasthan/story/patanjali-mustard-oil-substandard-quality-rajasthan-govt-1812995-2021-06-10|access-date=2021-06-30|magazine=India Today|language=en|archive-date=15 January 2024|archive-url=https://web.archive.org/web/20240115062519/https://www.indiatoday.in/india/rajasthan/story/patanjali-mustard-oil-substandard-quality-rajasthan-govt-1812995-2021-06-09|url-status=live}}</ref>


The move came after the product was tested at the central food lab that found the product unfit for consumption. After which, the CSD asked all its depots to make debit notes for their existing stock so that the product can be returned.<ref>https://hindustantimes.com/india-news/baba-ramdev-s-patanjali-products-fail-uttarakhand-quality-test/story-bXo4XySEajw7ZDby4GISML.html</ref><ref>{{cite news |url=https://www.businesstoday.in/lite/story/defence-canteens-remove-ramdevs-patanjali-amla-juice-after-adverse-lab-test-report/1/250631.html |title= Defence canteens remove Ramdev's Patanjali amla juice after adverse lab report|access-date=18 May 2020}}</ref>
=== {{anchor|Ayush Ministry}}Ayush Ministry against false advertisements===
[[Ministry of Ayush|Ministry of AYUSH]] has advised certain states to take necessary action against Baba Ramdev's Patanjali Ayurved for illegally promoting products that claimed to cure [[diabetes]], heart and liver diseases. The Ministry has specifically sought action against the advertisements of three Patanjali products — Lipidom, Livogrit and Livamrit.<ref>{{Cite web |date=2022-04-27 |title=Patanjali ads claiming to cure heart, liver issues come under govt scanner |url=https://www.thenewsminute.com/article/patanjali-ads-claiming-cure-heart-liver-issues-come-under-govt-scanner-163326 |access-date=2022-04-28 |website=The News Minute |language=en |archive-date=15 January 2024 |archive-url=https://web.archive.org/web/20240115062621/https://www.thenewsminute.com/article/patanjali-ads-claiming-cure-heart-liver-issues-come-under-govt-scanner-163326 |url-status=live }}</ref><ref>{{Cite news |date=2022-04-24 |title=AYUSH Ministry seeks action against advertisements by Ayurveda pharma |language=en-IN |work=The Hindu |url=https://www.thehindu.com/news/national/kerala/ayush-ministry-seeks-action-against-advertisements-by-ayurveda-pharma/article65351124.ece |access-date=2022-04-28 |issn=0971-751X |archive-date=15 January 2024 |archive-url=https://web.archive.org/web/20240115062544/https://www.thehindu.com/news/national/kerala/ayush-ministry-seeks-action-against-advertisements-by-ayurveda-pharma/article65351124.ece |url-status=live }}</ref><ref>{{Cite web |title=Glare on Patanjali for heart and liver products advertisements |url=https://www.telegraphindia.com/india/patanjali-under-scanner-for-advertisements-of-heart-and-liver-products/cid/1861587 |access-date=2022-04-28 |website=www.telegraphindia.com |archive-date=15 January 2024 |archive-url=https://web.archive.org/web/20240115062629/https://www.telegraphindia.com/india/patanjali-under-scanner-for-advertisements-of-heart-and-liver-products/cid/1861587 |url-status=live }}</ref>


===Notice by FSSAI===
===Fake COVID-19 treatment===
Patanjali launched [[instant noodles]] on 15 November 2015.<ref>{{cite news|url=http://www.thehindu.com/business/ramdevs-patanjali-launches-noodles/article7884161.ece|title=Ramdev's Patanjali launches noodles|work=The Hindu|date=16 November 2015}}</ref><ref>{{cite web|url=http://khabar.ibnlive.com/news/desh/baba-ramdev-maggie-fssai-notice-patanjali-428194.html|title=FSSAI sends notice to Baba Ramdev's company|work=ibnlive.com}}</ref><ref>{{cite news|url=http://navbharattimes.indiatimes.com/business/business-news/trouble-mounts-for-ramdevs-atta-noodles-fssai-issues-notice-to-patanjali-ayurved/articleshow/49870608.cms|title=Trouble mounts for Ramdev's Atta Noodles, FSSAI issues notice to Patanjali Ayurved|publisher=Navbharat Times}}</ref> [[Food Safety and Standards Authority of India]] slapped a notice on the company as neither Patanjali nor Aayush, which are the two brand names under which Patanjali got licenses, have got any approval for manufacturing instant noodles.<ref>{{cite news|url=http://www.ndtv.com/india-news/no-approval-for-patanjali-instant-noodles-says-food-safety-regulator-1244771|title=No Approval for Patanjali Instant Noodles, Says Food Safety Regulator|publisher=NDTV|date=18 November 2015}}</ref><ref>{{cite news|url=http://indianexpress.com/article/india/india-news-india/no-licence-for-noodles-fssai-slaps-showcause-on-patanjali/|title='No licence for noodles': FSSAI slaps showcause on Patanjali|date=21 November 2015|work=The Indian Express}}</ref><ref>{{cite news|url=http://www.oneindia.com/india/patanjali-s-atta-noodles-in-trouble-baba-ramdev-breaks-silence-modi-govt-controversy-1931379.html|title=Patanjali's Atta Noodles in trouble: Baba Ramdev breaks silence, drags Modi govt into controversy|publisher=oneindia.com|date=19 November 2015}}</ref><ref>{{cite news|url=http://www.livehindustan.com/news/national/article1-will-reply-at-the-earliest-when-we-get-notice-baba-ramdev-505128.html|title=Patanjali Atta noodles gets notice|publisher=livehindustan.com}}</ref> At [[Rajasthan]], [[mustard oil]] sold by Patanjali has been found to be substandard by the [[Food Safety and Standards Authority of India|Food Safety and Standards Authority]] Laboratory in [[Alwar]].<ref>{{Cite web|last1=JaipurJune 10|first1=Sharat Kumar|last2=June 10|first2=2021UPDATED|last3=Ist|first3=2021 05:02|title=Patanjali mustard oil found to be of substandard food quality: Rajasthan govt|url=https://www.indiatoday.in/india/rajasthan/story/patanjali-mustard-oil-substandard-quality-rajasthan-govt-1812995-2021-06-10|access-date=2021-06-30|website=India Today|language=en}}</ref>
Patanjali Ayurved announced a drug named Coronil for [[COVID-19]] treatment in June 2020, with Ramdev claiming that it cured the disease.<ref>{{Cite web|last=Kumar|first=Ravi Prakash|date=2020-06-23|title=Coronavirus treatment: Ramdev's Patanjali launches Coronil kit for ₹545|url=https://www.livemint.com/news/india/coronavirus-vaccine-coronil-patanjali-baba-ramdev-press-conference-live-updates-11592893304534.html|access-date=2020-06-24|website=Livemint|language=en|archive-date=15 January 2024|archive-url=https://web.archive.org/web/20240115062553/https://www.livemint.com/news/india/coronavirus-vaccine-coronil-patanjali-baba-ramdev-press-conference-live-updates-11592893304534.html|url-status=live}}</ref><ref>{{Cite web|date=2020-06-23|title=Baba Ramdev's Patanjali launches Ayurvedic medicine Coronil for coronavirus! All you need to know|url=https://www.financialexpress.com/lifestyle/health/coronil-covid-19-patanjali-ayurvedic-medicine-baba-ramdev-coronil-medicine-coronavirus/2000657/|access-date=2020-06-24|website=The Financial Express|language=en-US|archive-date=15 January 2024|archive-url=https://web.archive.org/web/20240115063036/https://www.financialexpress.com/lifestyle/health/coronil-covid-19-patanjali-ayurvedic-medicine-baba-ramdev-coronil-medicine-coronavirus/2000657/|url-status=live}}</ref><ref name="BBC Coronil">{{cite news|date=19 December 2020|title=Covid-19: Fake 'immunity booster' found on sale in London shops|work=BBC News|url=https://www.bbc.com/news/uk-england-london-55318095|access-date=21 December 2020|archive-date=15 January 2024|archive-url=https://web.archive.org/web/20240115063025/https://www.bbc.com/news/uk-england-london-55318095|url-status=live}}</ref> There was no clinical data to prove that the new drug was effective or even safe; this prompted a social-media backlash which questioned the role of the Ministry of AYUSH.<ref>{{cite news |last1=Narayanan |first1=Kavya |title=AYUSH Ministry is endangering people, jeopardising Ayurveda with lax response to Patanjali's Coronil and COVID-19, warn experts |url=https://www.firstpost.com/india/patanajali-covid-19-ayush-ministry-weak-response-ramdevs-coronil-stunt-endangers-people-jeopardises-ayurveda-homeopathy-8529151.html |access-date=29 June 2020 |work=Firstpost |date=28 June 2020 |archive-date=21 November 2020 |archive-url=https://web.archive.org/web/20201121014011/https://www.firstpost.com/india/patanajali-covid-19-ayush-ministry-weak-response-ramdevs-coronil-stunt-endangers-people-jeopardises-ayurveda-homeopathy-8529151.html |url-status=live }}</ref> Within hours of Coronil's introduction, the ministry issued a statement denying authorisation for the new drug and asking the company to stop selling (and advertising) it until the trial results were examined by medical authorities.<ref>{{Cite web|date=2020-06-23|title=Govt asks Patanjali to stop ads of Covid drug|url=https://www.hindustantimes.com/india-news/govt-asks-patanjali-to-stop-ads-of-covid-drug/story-zPdLluK7AXOngR2Jn0qKWO.html|access-date=2020-06-24|website=Hindustan Times|language=en|archive-date=15 January 2024|archive-url=https://web.archive.org/web/20240115063126/https://www.hindustantimes.com/india-news/govt-asks-patanjali-to-stop-ads-of-covid-drug/story-zPdLluK7AXOngR2Jn0qKWO.html|url-status=live}}</ref><ref>{{Cite web|title=Ramdev's Patanjali Asked By Government To Explain COVID Drug Claim|url=https://www.ndtv.com/india-news/coronavirus-india-ramdevs-patanjali-asked-for-details-of-covid-drug-claim-by-government-2251004|access-date=2020-06-24|website=NDTV.com|archive-date=15 January 2024|archive-url=https://web.archive.org/web/20240115063031/https://www.ndtv.com/india-news/coronavirus-india-ramdevs-patanjali-asked-for-details-of-covid-drug-claim-by-government-2251004|url-status=live}}</ref><ref>{{Cite web|title=Ayush Ministry Stops Patanjali From Selling, Advertising Purported Covid Medicine|url=https://www.bloombergquint.com/business/ayush-ministry-stops-patanjali-from-advertising-purported-covid-medicine|access-date=2020-06-24|website=BloombergQuint|date=23 June 2020 |language=en|archive-date=15 January 2024|archive-url=https://web.archive.org/web/20240115063033/https://www.ndtvprofit.com/business/ayush-ministry-stops-patanjali-from-advertising-purported-covid-medicine|url-status=live}}</ref> An official from the ayurved department of the [[government of Uttarakhand]] said that the approval application for Coronil had not mentioned COVID-19.<ref>{{cite news |title=Patanjali's Coronil approval application did not mention coronavirus: Licence officer |url=https://www.indiatoday.in/india/story/patanjali-ayurved-baba-ramdev-coronavirus-cure-coronil-ayush-ministry-1692242-2020-06-24 |access-date=29 June 2020 |work=India Today |date=24 June 2020 |archive-date=15 January 2024 |archive-url=https://web.archive.org/web/20240115063028/https://www.indiatoday.in/india/story/patanjali-ayurved-baba-ramdev-coronavirus-cure-coronil-ayush-ministry-1692242-2020-06-24 |url-status=live }}</ref>


=== Loan default by Ruchi Soya Industries ===
Laboratory tests showed that the drug did not contain any ingredients which could treat or prevent coronavirus infections. The Indian government allowed Patanjali Ayurved to market Coronil as an immunity booster (not a cure),<ref name="BBC Coronil"/> but the [[Government of Maharashtra]] has banned the sale of Coronil in the state. [[First information report]]s were filed in Bihar and Rajasthan against Ramdev, Balkrishna and others, accusing them of dishonesty and selling fake medicines.<ref name=HT_Coronil>{{cite news |last1=Afreen |first1=Jasra |title=Complaint filed in Bihar court against Baba Ramdev over Covid-19 medicine claim |url=https://www.hindustantimes.com/patna/complaint-filed-in-bihar-court-against-ramdev-over-covid-19-medicine-claim/story-UIEsPIZMoDsGZAE3TcDknK.html |access-date=29 June 2020 |work=Hindusthan Times |date=29 June 2020 |archive-date=15 January 2024 |archive-url=https://web.archive.org/web/20240115063045/https://www.hindustantimes.com/patna/complaint-filed-in-bihar-court-against-ramdev-over-covid-19-medicine-claim/story-UIEsPIZMoDsGZAE3TcDknK.html |url-status=live }}</ref><ref name=IE_Coronil>{{cite news |title=FIR against 5 over Covid-19 'medicine' claim: Ramdev, Patanjali MD booked for 'cheating' |url=https://indianexpress.com/article/india/fir-against-5-over-covid-medicine-claim-ramdev-patanjali-md-booked-for-cheating6479691/ |access-date=29 June 2020 |work=Indian Express |date=29 June 2020 |archive-date=15 January 2024 |archive-url=https://web.archive.org/web/20240115063131/https://indianexpress.com/article/india/fir-against-5-over-covid-medicine-claim-ramdev-patanjali-md-booked-for-cheating6479691/ |url-status=live }}</ref> Patanjali responded to the accusations, saying that they did not violate any procedures before the drug was launched.<ref>{{cite news |last1=Sahay |first1=Abhinav |title='All parameters met': Patanjali claims Coronil clinical trial details furnished to Centre |url=https://www.hindustantimes.com/india-news/all-parametres-met-patanjali-claims-coronil-clinical-trial-details-furnished-to-centre/story-wV0b2zhW4SNbd24VX4Gc6N.html |access-date=29 June 2020 |work=Hindusthan Times |date=24 June 2020 |archive-date=15 January 2024 |archive-url=https://web.archive.org/web/20240115063538/https://www.hindustantimes.com/india-news/all-parametres-met-patanjali-claims-coronil-clinical-trial-details-furnished-to-centre/story-wV0b2zhW4SNbd24VX4Gc6N.html |url-status=live }}</ref> A [[Madras High Court]] judge fined the company {{INRConvert|1000000}} for making false claims about the drug, and Patanjali withdrew its claim that Coronil could cure COVID-19. The UK drug regulator threatened action if unauthorized products were sold in the UK.<ref name="BBC Coronil" />
In April 2020, Ruchi Soya Industries, which was acquired by Patanjali in 2019 was revealed to be among the top 50 wilful loan defaulters of India, with a loan of {{INRConvert|2212|c|year=2020}} written off by the RBI. Ruchi Soya was a loan defaulter before being acquired by Patanjali Ayurved in a distress sale.<ref>{{Cite web|title=RBI writes off over Rs 68K cr. loans, Choksi among 50 top wilful defaulters: RTI|url=http://www.daijiworld.com/news/newsDisplay.aspx?newsID=701663|website=www.daijiworld.com}}</ref><ref>{{cite news|last1=Bharali|first1=Swapnil|date=30 April 2020|title=Baba Ramdev's newly Acquired Company Among Top 50 Loan Defaulters in Historic Write-Off|work=Guwahati Plus|url=https://www.guwahatiplus.com/article-detail/baba-ramdev-among-top-50-wilful-loan-defaulters-in-historic-write-off|access-date=26 June 2020}}</ref><ref>{{cite news|last1=Roy|first1=Arup|last2=Chatterjee|first2=Dev|date=29 April 2020|title=Over Rs 68,600-crore loans of wilful defaulters written off, says RBI|work=Business Standard|url=https://www.business-standard.com/article/finance/banks-wrote-off-rs-68-607-cr-debt-of-top-50-willful-defaulters-rbi-120042801692_1.html|access-date=26 June 2020}}</ref>


=== Fake COVID-19 treatment ===
The government of Maharashtra banned Coronil in the state in June 2020, with home minister [[Anil Deshmukh]] threatening the company with legal action if they did not observe the ban.<ref>{{cite news |last1=Shrivastava |first1=Sonu |title=Maharashtra bans Patanjali's COVID-19 medicine 'Coronil' |url=https://www.asianage.com/business/companies/260620/maharashtra-bans-patanjalis-covid-19-medicine-coronil.html |access-date=29 June 2020 |work=Asian Age |date=26 June 2020 |archive-date=15 January 2024 |archive-url=https://web.archive.org/web/20240115063646/https://www.asianage.com/business/companies/260620/maharashtra-bans-patanjalis-covid-19-medicine-coronil.html |url-status=live }}</ref> The Madras High Court also barred Patanjali Ayurved from using the name "Coronil".<ref name="theprint.in">{{Cite web|last1=Mandhani|first1=Apoorva|date=2020-08-06|title=Patanjali can't use Coronil trademark, says Madras High Court, fines it Rs 10 lakh|url=https://theprint.in/judiciary/patanjali-cant-use-coronil-trademark-says-madras-high-court-fines-it-rs-10-lakh/476461/|access-date=2021-02-18|website=ThePrint|language=en-US|archive-date=15 January 2024|archive-url=https://web.archive.org/web/20240115063550/https://theprint.in/judiciary/patanjali-cant-use-coronil-trademark-says-madras-high-court-fines-it-rs-10-lakh/476461/|url-status=live}}</ref><ref>{{Cite web|date=August 6, 2020|first=Shalini|last=Lobo|title=Patanjali chased profits by exploiting public fear: Madras HC imposes Rs 10 lakh fine on firm|url=https://www.indiatoday.in/india/story/madras-hc-restains-patanjali-from-trademarking-coronil-slaps-fine-of-rs-10-lakh-1708517-2020-08-06|access-date=2021-02-18|website=India Today|language=en|archive-date=15 January 2024|archive-url=https://web.archive.org/web/20240115063540/https://www.indiatoday.in/india/story/madras-hc-restains-patanjali-from-trademarking-coronil-slaps-fine-of-rs-10-lakh-1708517-2020-08-06|url-status=live}}</ref> The court's order came while it heard a suit filed by a Chennai-based firm which said that it had owned the trademark "Coronil" since 1993. Making an earlier interim injunction against Patanjali absolute, Madras High Court Justice C. V. Karthikeyan also imposed the fine on the company.<ref>{{Cite web|title=Madras HC: Patanjali cannot use 'Coronil' branding, must pay Rs 10 lakh fine for exploiting fear|url=https://www.cnbctv18.com/healthcare/madras-hc-patanjali-cannot-use-coronil-branding-must-pay-rs-10-lakh-fine-for-exploiting-fear-6565351.htm|access-date=2021-02-18|website=cnbctv18.com|date=6 August 2020|language=en-US|archive-date=15 January 2024|archive-url=https://web.archive.org/web/20240115063542/https://www.cnbctv18.com/healthcare/madras-hc-patanjali-cannot-use-coronil-branding-must-pay-rs-10-lakh-fine-for-exploiting-fear-6565351.htm|url-status=live}}</ref><ref>{{Cite web|date=2020-08-06|title=Patanjali exploited public fear says Madras HC, imposes Rs 10 lakh fine|url=https://www.thenewsminute.com/article/patanjali-exploited-public-fear-says-madras-hc-imposes-rs-10-lakh-fine-130196|access-date=2021-02-18|website=The News Minute|language=en|archive-date=15 January 2024|archive-url=https://web.archive.org/web/20240115064145/https://www.thenewsminute.com/article/patanjali-exploited-public-fear-says-madras-hc-imposes-rs-10-lakh-fine-130196|url-status=live}}</ref> In his ruling, the judge observed that Patanjali had been "chasing further profits by exploiting the fear and panic among the general public by projecting a cure for the coronavirus when their 'Coronil Tablet' is not a cure".<ref>{{Cite web|title=Patanjali Ayurved fined Rs 10 lakh by Madras HC for chasing profits by claiming COVID-19 'cure'|url=https://www.newindianexpress.com/states/tamil-nadu/2020/aug/06/patanjali-ayurved-fined-rs-10-lakh-by-madras-hc-for-chasing-profits-by-claiming-covid-19-cure-2180005.html|access-date=2021-02-18|website=The New Indian Express|date=6 August 2020 |archive-date=15 January 2024|archive-url=https://web.archive.org/web/20240115064154/https://www.newindianexpress.com/states/tamil-nadu/2020/aug/06/patanjali-ayurved-fined-rs-10-lakh-by-madras-hc-for-chasing-profits-by-claiming-covid-19-cure-2180005.html|url-status=live}}</ref><ref name="theprint.in"/><ref>{{Cite web|date=2020-08-06|title=Patanjali Fined Rs 10 Lakh by Madras HC for Chasing Profits amid Covid-19 Fear, Using Coronil Trademark|url=https://www.news18.com/news/india/patanjali-fined-rs-10-lakh-by-madras-hc-for-chasing-profits-amid-covid-19-fear-using-coronil-trademark-2764771.html|access-date=2021-02-18|website=News18|language=en|archive-date=15 January 2024|archive-url=https://web.archive.org/web/20240115064051/https://www.news18.com/news/india/patanjali-fined-rs-10-lakh-by-madras-hc-for-chasing-profits-amid-covid-19-fear-using-coronil-trademark-2764771.html|url-status=live}}</ref> [[Nepal]] and [[Bhutan]] halted the distribution of donated Coronil after orders from their governments to disclose that it was not a medicine to cure COVID-19.<ref>{{Cite news|last=Bhattacherjee|first=Kallol|date=2021-06-08|title=Nepal stops distribution of Coronil kits gifted by Patanjali|language=en-IN|work=The Hindu|url=https://www.thehindu.com/news/international/nepal-stops-distribution-of-patanjalis-coronil-kits/article34762927.ece|access-date=2021-06-30|issn=0971-751X|archive-date=15 January 2024|archive-url=https://web.archive.org/web/20240115064053/https://www.thehindu.com/news/international/nepal-stops-distribution-of-patanjalis-coronil-kits/article34762927.ece|url-status=live}}</ref><ref>{{Cite magazine|author=Geeta Mohan|date=June 9, 2021|title=Nepal stops distribution of Coronil kits gifted by Patanjali, cites lack of proof on efficacy|url=https://www.indiatoday.in/coronavirus-outbreak/story/nepal-stops-distribution-patanjali-coronil-ramdev-1812665-2021-06-09|access-date=2021-06-30|magazine=India Today|language=en|archive-date=15 January 2024|archive-url=https://web.archive.org/web/20240115064148/https://www.indiatoday.in/coronavirus-outbreak/story/nepal-stops-distribution-patanjali-coronil-ramdev-1812665-2021-06-09|url-status=live}}</ref>
In June 2020, Patanjali Ayurved announced a drug named Coronil for [[COVID-19]] treatment, and Ramdev claimed that it cured Covid-19 patients.<ref>{{Cite web|last=Kumar|first=Ravi Prakash|date=2020-06-23|title=Coronavirus treatment: Ramdev's Patanjali launches Coronil kit for ₹545|url=https://www.livemint.com/news/india/coronavirus-vaccine-coronil-patanjali-baba-ramdev-press-conference-live-updates-11592893304534.html|access-date=2020-06-24|website=Livemint|language=en}}</ref><ref>{{Cite web|date=2020-06-23|title=Baba Ramdev's Patanjali launches Ayurvedic medicine Coronil for coronavirus! All you need to know|url=https://www.financialexpress.com/lifestyle/health/coronil-covid-19-patanjali-ayurvedic-medicine-baba-ramdev-coronil-medicine-coronavirus/2000657/|access-date=2020-06-24|website=The Financial Express|language=en-US}}</ref><ref name="BBC Coronil">{{cite news|date=19 December 2020|title=Covid-19: Fake 'immunity booster' found on sale in London shops|work=BBC News|url=https://www.bbc.com/news/uk-england-london-55318095|access-date=21 December 2020}}</ref> There was no clinical data to prove that these new drugs were effective or even safe, and this prompted a backlash on social media, with people questioning the role of the [[Ministry of AYUSH]].<ref>{{cite news |last1=Narayanan |first1=Kavya |title=AYUSH Ministry is endangering people, jeopardising Ayurveda with lax response to Patanjali's Coronil and COVID-19, warn experts |url=https://www.firstpost.com/india/patanajali-covid-19-ayush-ministry-weak-response-ramdevs-coronil-stunt-endangers-people-jeopardises-ayurveda-homeopathy-8529151.html |access-date=29 June 2020 |work=Firstpost |date=28 June 2020}}</ref> Within hours of the launch, the Ministry of AYUSH issued a statement, denying having given clearance for the launch of the new drugs and asking the company to stop selling or advertising the product until the trial results were examined by medical authorities.<ref>{{Cite web|date=2020-06-23|title=Govt asks Patanjali to stop ads of Covid drug|url=https://www.hindustantimes.com/india-news/govt-asks-patanjali-to-stop-ads-of-covid-drug/story-zPdLluK7AXOngR2Jn0qKWO.html|access-date=2020-06-24|website=Hindustan Times|language=en}}</ref><ref>{{Cite web|title=Ramdev's Patanjali Asked By Government To Explain COVID Drug Claim|url=https://www.ndtv.com/india-news/coronavirus-india-ramdevs-patanjali-asked-for-details-of-covid-drug-claim-by-government-2251004|access-date=2020-06-24|website=NDTV.com}}</ref><ref>{{Cite web|title=Ayush Ministry Stops Patanjali From Selling, Advertising Purported Covid Medicine|url=https://www.bloombergquint.com/business/ayush-ministry-stops-patanjali-from-advertising-purported-covid-medicine|access-date=2020-06-24|website=BloombergQuint|language=en}}</ref> An officer from the Ayurved department of the [[Government of Uttarakhand]] stated that the approval application for the new drugs had not mentioned COVID-19.<ref>{{cite news |title=Patanjali's Coronil approval application did not mention coronavirus: Licence officer |url=https://www.indiatoday.in/india/story/patanjali-ayurved-baba-ramdev-coronavirus-cure-coronil-ayush-ministry-1692242-2020-06-24 |access-date=29 June 2020 |work=India Today |date=24 June 2020}}</ref>


Lab tests have shown that the drug did not contain any ingredients that could treat coronavirus infections, nor protect against such infections. The Indian government allowed Patanjali Ayurved to market Coronil as an immunity booster but not as a cure,<ref name="BBC Coronil">{{cite news|date=19 December 2020|title=Covid-19: Fake 'immunity booster' found on sale in London shops|work=BBC News|url=https://www.bbc.com/news/uk-england-london-55318095|access-date=21 December 2020}}</ref> but the [[Government of Maharashtra]] has banned the sale of Coronil in the state. Lawsuits were filed in Bihar and Rajasthan against Ramdev, Balkrishna, and others, accusing them of cheating and selling fake medicines.<ref name=HT_Coronil /><ref name=IE_Coronil /> The [[Madras High Court]] has fined the company {{INRConvert|1000000}} for making false claims about the drug. Patanjali has withdrawn the claim of Coronil being a cure for Covid-19. The UK drug regulator has threatened action, if unauthorized products were sold in the UK market.<ref name="BBC Coronil" /> In February 2021, the company claimed that Coronil had received a [[WHO]] certification for use against Coronavirus. These claims were withdrawn after it had been shown that the approval did not come from the WHO, nor did it address the effectiveness of the drug, but was a [[Good manufacturing practice|GMP]] licence from the [[Drugs Controller General of India]] regarding the manufacturing of the product.<ref>{{cite news |last1=Menon |first1=Shruti |title=Coronavirus: The misleading claims about an Indian remedy |url=https://www.bbc.com/news/56172784 |access-date=26 May 2021 |work=BBC Reality Check |date=2 March 2021}}</ref>
===={{anchor|False claims regarding government and WHO approvals}}False claims of government and WHO approvals====
In February 2021, ''[[The Indian Express]]'', ''[[The Times of India]]'', ''[[The Hindu]]'' ''and [[Mint (newspaper)|Livemint]]'' reported Patanjali Ayurved's claim that Coronil had been approved by the Ministry of AYUSH and certified by the [[World Health Organization]]. The reports indicated that Ramdev had released studies showing that Coronil was effective against COVID-19 at a press conference attended by Union Health Minister [[Harsh Vardhan (Delhi politician)|Harsh Vardhan]] and transport minister [[Nitin Gadkari]].<ref>{{Cite web|date=2021-02-20|title=Coronil has received AYUSH certification as per WHO norms: Patanjali|url=https://indianexpress.com/article/india/coronil-ayush-ministry-certification-who-scheme-patanjali-7195575/|url-status=live|archive-url=https://web.archive.org/web/20210219085748/https://indianexpress.com/article/india/coronil-ayush-ministry-certification-who-scheme-patanjali-7195575/|archive-date=19 February 2021|access-date=2021-02-21|website=The Indian Express|language=en}}</ref><ref>{{Cite web|date=2021-02-19|title=Coronil has received Ayush Ministry certification as per WHO scheme: Patanjali|url=https://www.livemint.com/news/india/coronil-has-received-ayush-ministry-certification-as-per-who-scheme-patanjali-11613745938737.html|url-status=live|archive-url=https://web.archive.org/web/20210219164744/https://www.livemint.com/news/india/coronil-has-received-ayush-ministry-certification-as-per-who-scheme-patanjali-11613745938737.html|archive-date=19 February 2021|access-date=2021-02-21|website=mint|language=en}}</ref><ref>{{Cite web|date=19 February 2021|title=Patanjali Coronil: Coronil gets Ayush ministry certification as per WHO scheme: Patanjali|url=https://timesofindia.indiatimes.com/business/india-business/coronil-gets-ayush-ministry-certification-as-per-who-scheme-patanjali/articleshow/81107648.cms|url-status=live|archive-url=https://web.archive.org/web/20210220115523/https://timesofindia.indiatimes.com/business/india-business/coronil-gets-ayush-ministry-certification-as-per-who-scheme-patanjali/articleshow/81107648.cms|archive-date=20 February 2021|access-date=2021-02-21|website=The Times of India|language=en}}</ref><ref>{{Cite news|agency=PTI|date=2021-02-19|title=Coronil gets Ayush Ministry certification as 'supporting measure' for COVID-19 treatment|language=en-IN|work=The Hindu|url=https://www.thehindu.com/business/Industry/coronil-gets-ayush-ministry-certification-as-per-who-scheme-patanjali/article33878394.ece|access-date=2021-02-21|issn=0971-751X|archive-date=15 January 2024|archive-url=https://web.archive.org/web/20240115064147/https://www.thehindu.com/business/Industry/coronil-gets-ayush-ministry-certification-as-per-who-scheme-patanjali/article33878394.ece|url-status=live}}</ref> In a ''[[News Nation]]'' interview, Ramdev accused doctors of "allopathic terrorism" for doubting Coronil's effectiveness.<ref name=":0">{{Cite web|last=Chaudhuri|first=Pooja|date=2021-02-21|title=Fact Check: Patanjali's Coronil Neither WHO Certified nor Approved|url=https://science.thewire.in/health/fact-check-patanjalis-coronil-neither-who-certified-nor-approved/|access-date=2021-02-21|website=The Wire Science|language=en-GB|archive-date=15 January 2024|archive-url=https://web.archive.org/web/20240115064130/https://science.thewire.in/health/fact-check-patanjalis-coronil-neither-who-certified-nor-approved/|url-status=live}}</ref> The claim was endorsed by [[Bharatiya Janata Party]] spokesperson Sanju Verma, who called it "... a huge endorsement for Ayurveda India's homegrown StartUp ecosystem that has flourished under @narendramodi govt."<ref name=":0" /> Verma described the approvals granted to Coronil as a "slap in the face" to the BJP's opposition.<ref>{{Cite web|date=19 February 2021|title=Tweet: @Sanju_Verma|url=https://twitter.com/Sanju_Verma_/status/1362747173075488778?s=20|website=Twitter}}</ref>


The [[Government of Maharashtra]] banned Coronil in the state in June 2020, with home minister [[Anil Deshmukh]] threatening the company with legal action if they did not respect the ban.<ref>{{cite news |last1=Shrivastava |first1=Sonu |title=Maharashtra bans Patanjali's COVID-19 medicine 'Coronil'..|url=https://www.asianage.com/business/companies/260620/maharashtra-bans-patanjalis-covid-19-medicine-coronil.html |access-date=29 June 2020 |work=Asian Age |date=26 June 2020}}</ref> Following the launch two FIRs were registered in Bihar and Rajasthan against Ramdev, Balkrishna, and others, accusing them of cheating and selling fake medicines.<ref name=HT_Coronil>{{cite news |last1=Afreen |first1=Jasra |title=Complaint filed in Bihar court against Baba Ramdev over Covid-19 medicine claim |url=https://www.hindustantimes.com/patna/complaint-filed-in-bihar-court-against-ramdev-over-covid-19-medicine-claim/story-UIEsPIZMoDsGZAE3TcDknK.html |access-date=29 June 2020 |work=Hindusthan Times |date=29 June 2020}}</ref><ref name=IE_Coronil>{{cite news |title=FIR against 5 over Covid-19 'medicine' claim: Ramdev, Patanjali MD booked for 'cheating' |url=https://indianexpress.com/article/india/fir-against-5-over-covid-medicine-claim-ramdev-patanjali-md-booked-for-cheating6479691/ |access-date=29 June 2020 |work=Indian Express |date=29 June 2020}}</ref> Patanjali responded to the accusations claiming that they did not violate any procedure leading up to the launch.<ref>{{cite news |last1=Sahay |first1=Abhinav |title='All parameters met': Patanjali claims Coronil clinical trial details furnished to Centre |url=https://www.hindustantimes.com/india-news/all-parametres-met-patanjali-claims-coronil-clinical-trial-details-furnished-to-centre/story-wV0b2zhW4SNbd24VX4Gc6N.html |access-date=29 June 2020 |work=Hindusthan Times |date=24 June 2020}}</ref> Patanjali has withdrawn the claim of Coronil being a cure for Covid-19.<ref name="BBC Coronil" />
On 22 February, the WHO said that it had not "... reviewed or certified the effectiveness of any traditional medicine for the treatment #Covid19."<ref>{{Cite web|last=Awasthi|first=Prashasti|title=WHO clarifies it hasn't reviewed or certified Coronil for Covid-19 treatment|url=https://www.thehindubusinessline.com/news/world/who-clarifies-it-hasnt-reviewed-or-certified-coronil-for-covid-19-treatment/article33893901.ece|access-date=2021-02-21|website=@businessline|date=21 February 2021 |language=en}}</ref> Several news and [[fact-checking]] outlets, including ''[[The Wire (India)|The Wire]]'', ''[[Alt News]]'', [[BBC News]] and ''[[The Economic Times]]'', ran fact-checking articles debunking Ramdev and Patanjali's claims; Coronil had received an export license, and had not received any approval regarding its effectiveness as a treatment against COVID-19.<ref name=":1">{{Cite news|last=Bhushan|first=Ratna|title=Patanjali's Coronil not WHO certified or approved; no traditional medicine certified by WHO for Covid cure|work=The Economic Times|url=https://economictimes.indiatimes.com/industry/cons-products/fmcg/patanjalis-coronil-not-who-certified-or-approved-no-traditional-medicine-certified-by-who-for-covid-cure/articleshow/81134456.cms|access-date=2021-02-21}}</ref><ref>{{Cite web|date=2021-02-20|title=Patanjali's Coronil is neither WHO certified nor approved, media outlets run false news|url=https://www.altnews.in/patanjalis-coronil-is-neither-who-certified-nor-approved-media-outlets-run-false-news/|access-date=2021-02-21|website=Alt News|language=en-GB|archive-date=15 January 2024|archive-url=https://web.archive.org/web/20240115064232/https://www.altnews.in/patanjalis-coronil-is-neither-who-certified-nor-approved-media-outlets-run-false-news/|url-status=live}}</ref><ref name=":0" /><ref>{{cite news |last1=Menon |first1=Shruti |title=Coronavirus: The misleading claims about an Indian remedy |url=https://www.bbc.com/news/56172784 |access-date=26 May 2021 |work=BBC Reality Check |date=2 March 2021 |archive-date=15 January 2024 |archive-url=https://web.archive.org/web/20240115064722/https://www.bbc.com/news/56172784 |url-status=live }}</ref> Patanjali Ayurveda CEO Balkrishna admitted on Twitter that the approval for Coronil had not come from the WHO or the Ministry of AYUSH (as they had claimed), but had been granted by the [[Drugs Controller General of India]] for export{{snd}}not as a certification of effectiveness.<ref name=":0" /><ref name=":1" />


The Madras High Court has also barred Patanjali Ayurved from using the trademark ‘Coronil’.<ref name="theprint.in">{{Cite web|last1=M|first1=Apoorva|last2=hani|date=2020-08-06|title=Patanjali can't use Coronil trademark, says Madras High Court, fines it Rs 10 lakh|url=https://theprint.in/judiciary/patanjali-cant-use-coronil-trademark-says-madras-high-court-fines-it-rs-10-lakh/476461/|access-date=2021-02-18|website=ThePrint|language=en-US}}</ref><ref>{{Cite web|date=August 6, 2020|first=Shalini|last=Lobo|title=Patanjali chased profits by exploiting public fear: Madras HC imposes Rs 10 lakh fine on firm|url=https://www.indiatoday.in/india/story/madras-hc-restains-patanjali-from-trademarking-coronil-slaps-fine-of-rs-10-lakh-1708517-2020-08-06|access-date=2021-02-18|website=India Today|language=en}}</ref> The court’s order came while hearing a suit filed by a Chennai-based firm that claimed that ‘Coronil’ is a trademark owned by it since 1993. While making an absolute interim injunction passed earlier against Patanjali, Justice C.V. Karthikeyan also imposed a fine of Rs 10 lakh on the company.<ref>{{Cite web|title=Madras HC: Patanjali cannot use 'Coronil' branding, must pay Rs 10 lakh fine for exploiting fear|url=https://www.cnbctv18.com/healthcare/madras-hc-patanjali-cannot-use-coronil-branding-must-pay-rs-10-lakh-fine-for-exploiting-fear-6565351.htm|access-date=2021-02-18|website=cnbctv18.com|language=en-US}}</ref><ref>{{Cite web|date=2020-08-06|title=Patanjali exploited public fear says Madras HC, imposes Rs 10 lakh fine|url=https://www.thenewsminute.com/article/patanjali-exploited-public-fear-says-madras-hc-imposes-rs-10-lakh-fine-130196|access-date=2021-02-18|website=The News Minute|language=en}}</ref> The judge in its ruling also observed that Patanjali has been “chasing further profits by exploiting the fear and panic among the general public by projecting a cure for the coronavirus when their ‘Coronil Tablet’ is not a cure”.<ref>{{Cite web|title=Patanjali Ayurved fined Rs 10 lakh by Madras HC for chasing profits by claiming COVID-19 'cure'|url=https://www.newindianexpress.com/states/tamil-nadu/2020/aug/06/patanjali-ayurved-fined-rs-10-lakh-by-madras-hc-for-chasing-profits-by-claiming-covid-19-cure-2180005.html|access-date=2021-02-18|website=The New Indian Express}}</ref><ref name="theprint.in"/><ref>{{Cite web|date=2020-08-06|title=Patanjali Fined Rs 10 Lakh by Madras HC for Chasing Profits amid Covid-19 Fear, Using Coronil Trademark|url=https://www.news18.com/news/india/patanjali-fined-rs-10-lakh-by-madras-hc-for-chasing-profits-amid-covid-19-fear-using-coronil-trademark-2764771.html|access-date=2021-02-18|website=News18|language=en}}</ref>
===Taking control over Dalits' lands===
In August 2022, [[Newslaundry]] published a report alleging that Patanjali took control of [[Dalit]]s' lands for cow shelter and herb farms in Teliwala village, Uttarkhand through force and circumvention of laws, making people there landless.<ref>{{cite news |last1=Kumar |first1=Basant |title=How Ramdev's Patanjali took control of Dalit lands in Haridwar |url=https://www.newslaundry.com/2022/08/19/how-ramdevs-patanjali-took-control-of-dalit-lands-in-haridwar |access-date=2022-08-31 |work=[[Newslaundry]] |date=2022-08-19 |archive-date=15 January 2024 |archive-url=https://web.archive.org/web/20240115064723/https://www.newslaundry.com/2022/08/19/how-ramdevs-patanjali-took-control-of-dalit-lands-in-haridwar |url-status=live }}</ref> With their land in control of Patanjali, Dalits have no choice other than working for the company or migrating elsewhere for finding employment.


Countries like [[Nepal]] & [[Bhutan]] have stopped the distribution of Coronil kits after the order from Government to clarify that it's not an equivalent to medicines to defeat [[COVID-19]] virus.<ref>{{Cite news|last=Bhattacherjee|first=Kallol|date=2021-06-08|title=Nepal stops distribution of Coronil kits gifted by Patanjali|language=en-IN|work=The Hindu|url=https://www.thehindu.com/news/international/nepal-stops-distribution-of-patanjalis-coronil-kits/article34762927.ece|access-date=2021-06-30|issn=0971-751X}}</ref><ref>{{Cite web|last1=DelhiJune 9|first1=Geeta Mohan New|last2=June 9|first2=2021UPDATED|last3=Ist|first3=2021 18:12|title=Nepal stops distribution of Coronil kits gifted by Patanjali, cites lack of proof on efficacy|url=https://www.indiatoday.in/coronavirus-outbreak/story/nepal-stops-distribution-patanjali-coronil-ramdev-1812665-2021-06-09|access-date=2021-06-30|website=India Today|language=en}}</ref>
===Accusations of using fish bones in veg product===
In May 2023, a Delhi-based law firm issued a legal notice to Patanjali Ayurved accusing the company of using 'cuttlefish bones' in dental care product, branding non-veg product as vegetarian in violation of the law.<ref>{{cite news |last1=Dutta |first1=Sumi Sukanya |title=Patanjali gets legal notice for using 'cuttlefish bones' in dental care product marked vegetarian |url=https://theprint.in/india/patanjali-gets-legal-notice-for-using-cuttlefish-bones-in-dental-care-product-marked-vegetarian/1581342/ |access-date=2023-05-18 |work=[[ThePrint]] |date=2023-05-18 |archive-date=15 January 2024 |archive-url=https://web.archive.org/web/20240115064725/https://theprint.in/india/patanjali-gets-legal-notice-for-using-cuttlefish-bones-in-dental-care-product-marked-vegetarian/1581342/ |url-status=live }}</ref>


==== False claims regarding government and WHO approvals ====
=== Misleading advertising case ===
In February 2021, several news outlets, including ''[[The Indian Express|Indian Express]], [[The Times of India|Times of India]], The Hindu'', ''and [[Mint (newspaper)|Livemint]]'' carried reports that Patanjali Ayurved claimed that Coronil had received approval from the Ministry of AYUSH as well as certification from the World Health Organization. These reports indicated that [[Ramdev]] had, at a press conference attended by Union Health Minister [[Harsh Vardhan (Delhi politician)|Harsh Vardhan]] and transport minister [[Nitin Gadkari]], released studies showing that Coronil was effective against [[COVID-19]].<ref>{{Cite web|date=2021-02-20|title=Coronil has received AYUSH certification as per WHO norms: Patanjali|url=https://indianexpress.com/article/india/coronil-ayush-ministry-certification-who-scheme-patanjali-7195575/|url-status=live|archive-url=https://web.archive.org/web/20210219085748/https://indianexpress.com/article/india/coronil-ayush-ministry-certification-who-scheme-patanjali-7195575/|archive-date=19 February 2021|access-date=2021-02-21|website=The Indian Express|language=en}}</ref><ref>{{Cite web|date=2021-02-19|title=Coronil has received Ayush Ministry certification as per WHO scheme: Patanjali|url=https://www.livemint.com/news/india/coronil-has-received-ayush-ministry-certification-as-per-who-scheme-patanjali-11613745938737.html|url-status=live|archive-url=https://web.archive.org/web/20210219164744/https://www.livemint.com/news/india/coronil-has-received-ayush-ministry-certification-as-per-who-scheme-patanjali-11613745938737.html|archive-date=19 February 2021|access-date=2021-02-21|website=mint|language=en}}</ref><ref>{{Cite web|last1=PTI|last2=2021|date=19 February 2021|title=Patanjali coronil: Coronil gets Ayush ministry certification as per WHO scheme: Patanjali|url=https://timesofindia.indiatimes.com/business/india-business/coronil-gets-ayush-ministry-certification-as-per-who-scheme-patanjali/articleshow/81107648.cms|url-status=live|archive-url=https://web.archive.org/web/20210220115523/https://timesofindia.indiatimes.com/business/india-business/coronil-gets-ayush-ministry-certification-as-per-who-scheme-patanjali/articleshow/81107648.cms|archive-date=19 February 2021|access-date=2021-02-21|website=The Times of India|language=en}}</ref><ref>{{Cite news|others=PTI|date=2021-02-19|title=Coronil gets Ayush Ministry certification as 'supporting measure' for COVID-19 treatment|language=en-IN|work=The Hindu|url=https://www.thehindu.com/business/Industry/coronil-gets-ayush-ministry-certification-as-per-who-scheme-patanjali/article33878394.ece|access-date=2021-02-21|issn=0971-751X}}</ref> The claim was first reported by Channel ''[[News Nation]]'', which did an exclusive interview with Ramdev, in which he accused medical doctors of engaging in 'allopathic terrorism' concerning doubts about the effectiveness of Coronil.<ref name=":0">{{Cite web|last=Chaudhuri|first=Pooja|date=2021-02-21|title=Fact Check: Patanjali's Coronil Neither WHO Certified nor Approved|url=https://science.thewire.in/health/fact-check-patanjalis-coronil-neither-who-certified-nor-approved/|access-date=2021-02-21|website=The Wire Science|language=en-GB}}</ref> The claim was endorsed by [[Bharatiya Janata Party]] spokesperson, Sanju Verma, who described it as a "....a huge endorsement for Ayurveda India's homegrown StartUp ecosystem that has flourished under @narendramodi govt."<ref name=":0" /> Verma, speaking for the BJP, also described the approvals granted to Coronil as a "slap in the face" to the BJP's political opposition.<ref>{{Cite web|date=19 February 2021|title=Tweet: @Sanju_Verma|url=https://twitter.com/Sanju_Verma_/status/1362747173075488778?s=20|url-status=live|website=Twitter}}</ref>
The company has been accused of misleading advertising<ref>{{Cite web|title=Patanjali Advertisements Unsubstantiated, Misleading: Watchdog|url=https://www.ndtv.com/business/patanjali-advertisements-unsubstantiated-misleading-says-watchdog-1427896|access-date=2021-05-02|website=NDTV.com|date=4 July 2016 |archive-date=15 January 2024|archive-url=https://web.archive.org/web/20240115061448/https://www.ndtvprofit.com/business/patanjali-advertisements-unsubstantiated-misleading-says-watchdog-1427896|url-status=live}}</ref><ref>{{Cite web|title=Patanjali Ayurved Rapped For Misleading Hair Oil, Other Advertisements|url=https://www.ndtv.com/business/patanjali-ayurved-rapped-for-misleading-hair-oil-other-advertisements-1412436|access-date=2021-05-02|website=NDTV.com|date=26 May 2016 |archive-date=15 January 2024|archive-url=https://web.archive.org/web/20240115061415/https://www.ndtvprofit.com/business/patanjali-ayurved-rapped-for-misleading-hair-oil-other-advertisements-1412436|url-status=live}}</ref> about its products and flimsy testing before being marketed.<ref>{{Cite web|date=2017-05-29|title=Ramdev's Patanjali products fail quality test, RTI inquiry finds|url=https://www.hindustantimes.com/india-news/baba-ramdev-s-patanjali-products-fail-uttarakhand-quality-test/story-bXo4XySEajw7ZDby4GISML.html|access-date=2020-10-07|website=Hindustan Times|language=en|archive-date=15 January 2024|archive-url=https://web.archive.org/web/20240115061414/https://www.hindustantimes.com/india-news/baba-ramdev-s-patanjali-products-fail-uttarakhand-quality-test/story-bXo4XySEajw7ZDby4GISML.html|url-status=live}}</ref> Between April 2015 and July 2016, 33 complaints were received against 21 misleading advertisements; seventeen violated [[Advertising Standards Council of India|ASCI]] standards.<ref>{{Cite web|title=33 Complaints Received Against Patanjali Advertisements|url=https://www.ndtv.com/business/33-complaints-received-against-patanjali-advertisements-1439145|access-date=2021-05-02|website=NDTV.com|date=2 August 2016 |archive-date=15 January 2024|archive-url=https://web.archive.org/web/20240115061448/https://www.ndtvprofit.com/business/33-complaints-received-against-patanjali-advertisements-1439145|url-status=live}}</ref> In September 2017, the [[Delhi High Court]] ordered the company to stop airing an advertisement for its brand of [[chyavanprash]] which disparaged a competitor's.<ref>{{Cite web|date=7 September 2017|title=Delhi Court Restrains Patanjali From Airing Ads Promoting Chyawanprash|url=https://www.ndtv.com/india-news/delhi-court-restrains-patanjali-from-airing-ads-promoting-chyawanprash-1747432|url-status=live|archive-url=https://web.archive.org/web/20170911112632/https://www.ndtv.com/india-news/delhi-court-restrains-patanjali-from-airing-ads-promoting-chyawanprash-1747432|archive-date=2017-09-11|access-date=2021-05-02|website=NDTV.com}}</ref> Company products, such as [[Phyllanthus emblica|amla]] juice<ref name="CSD withdraws">{{Cite web|last=Dangwal|first=Sandhya|date=2017-04-24|title=CSD withdraws Baba Ramdev's popular product after lab declares it unfit for consumption|url=https://www.india.com/business/patanjali-amla-juice-banned-csd-withdraws-baba-ramdevs-popular-product-after-lab-declares-it-unfit-for-consumption-2062146/|access-date=2020-10-07|website=India News, Breaking News, Entertainment News {{!}} India.com|language=en|archive-date=15 January 2024|archive-url=https://web.archive.org/web/20240115061449/https://www.india.com/business/patanjali-amla-juice-banned-csd-withdraws-baba-ramdevs-popular-product-after-lab-declares-it-unfit-for-consumption-2062146/|url-status=live}}</ref><ref name="sayingtruth.com">{{Cite web|date=2017-04-24|title=Military Canteens Ban sales of Patanjali Amla Juice|url=https://www.sayingtruth.com/patanjali-amla-juice-banned/|access-date=2020-10-07|website=Saying Truth|language=en-US|archive-date=15 January 2024|archive-url=https://web.archive.org/web/20240115061458/https://www.sayingtruth.com/patanjali-amla-juice-banned/|url-status=live}}</ref> and ayurvedic medicines<ref>{{Cite web|date=2017-06-22|title=Nepal drug administration reject six Patanjali products after tests, contain pathogenic bacteria|url=https://www.firstpost.com/india/nepal-drug-administration-reject-six-patanjali-products-after-tests-contain-pathogenic-bacteria-3735231.html|access-date=2020-10-07|website=Firstpost|archive-date=15 January 2024|archive-url=https://web.archive.org/web/20240115061522/https://www.firstpost.com/india/nepal-drug-administration-reject-six-patanjali-products-after-tests-contain-pathogenic-bacteria-3735231.html|url-status=live}}</ref> have been banned for poor quality.<ref name="sayingtruth.com" /><ref name="Quality test and RTI inquiry">{{cite web |url=https://www.hindustantimes.com/india-news/baba-ramdev-s-patanjali-products-fail-uttarakhand-quality-test/story-bXo4XySEajw7ZDby4GISML.html |title=Ramdev's Patanjali products fail quality test, RTI inquiry finds |author=<!--Not stated--> |date=30 May 2017 |publisher=Hindustan Times |access-date=21 December 2020 |archive-date=15 January 2024 |archive-url=https://web.archive.org/web/20240115061539/https://www.hindustantimes.com/india-news/baba-ramdev-s-patanjali-products-fail-uttarakhand-quality-test/story-bXo4XySEajw7ZDby4GISML.html |url-status=live }}</ref>


In response to these claims, the World Health Organisation on 22 February clarified that it had not "...reviewed or certified the effectiveness of any traditional medicine for the treatment #Covid19.<ref>{{Cite web|last=Awasthi|first=Prashasti|title=WHO clarifies it hasn't reviewed or certified Coronil for Covid-19 treatment|url=https://www.thehindubusinessline.com/news/world/who-clarifies-it-hasnt-reviewed-or-certified-coronil-for-covid-19-treatment/article33893901.ece|access-date=2021-02-21|website=@businessline|language=en}}</ref> Several news and fact-checking outlets, including ''[[The Wire (India)|The Wire]], [[Alt News]],'' and [https://economictimes.indiatimes.com/ Economic Times] ran fact-checking articles debunking the claims made by Ramdev and Patanjali, and demonstrating that Coronil had merely received a license for export, and had not received any approval regarding its effectiveness as a treatment against Covid-19.<ref name=":1">{{Cite news|last=Bhushan|first=Ratna|title=Patanjali's Coronil not WHO certified or approved; no traditional medicine certified by WHO for Covid cure|work=The Economic Times|url=https://economictimes.indiatimes.com/industry/cons-products/fmcg/patanjalis-coronil-not-who-certified-or-approved-no-traditional-medicine-certified-by-who-for-covid-cure/articleshow/81134456.cms|access-date=2021-02-21}}</ref><ref>{{Cite web|date=2021-02-20|title=Patanjali's Coronil is neither WHO certified nor approved, media outlets run false news|url=https://www.altnews.in/patanjalis-coronil-is-neither-who-certified-nor-approved-media-outlets-run-false-news/|access-date=2021-02-21|website=Alt News|language=en-GB}}</ref><ref name=":0" /> Following this, the CEO of Patanjali Ayurveda, Acharya Balkrishna, admitted on Twitter that the approval received for Coronil had not come from either the WHO or the Ministry of AYUSH, as they had earlier claimed, but had been granted by the [[Drugs Controller General of India]] only for exports, and not as a certification of effectiveness.<ref name=":0" /><ref name=":1" />
Patanjali was sued by the Indian Medical Association in August 2022 for attacking allopathy to promote its medicines, violating DOMA and the Consumer Protection Act, 2019. The Supreme Court accused Patanjali of misleading marketing in November 2023 and threatened a Rs 1 crore per product fine for bogus promises.<ref>{{cite news |last1=Kalia |first1=Saumya |title=Supreme Court's ban on Patanjali ads {{!}} Explained |url=https://www.thehindu.com/news/national/supreme-courts-ban-on-patanjali-ads-explained/article67899090.ece |access-date=25 May 2024 |work=[[The Hindu]] |date=3 March 2024}}</ref><ref>{{cite news |last1=Rajagopal |first1=Krishnadas |title=Supreme Court issues contempt notice to Patanjali, its MD Balkrishna |url=https://www.thehindu.com/news/national/supreme-court-comes-down-heavily-on-patanjali-for-prima-facie-violation-of-undertaking-on-claims-ads/article67891696.ece |access-date=28 February 2024 |work=[[The Hindu]] |date=27 February 2024 |archive-url=https://web.archive.org/web/20240227183532/https://www.thehindu.com/news/national/supreme-court-comes-down-heavily-on-patanjali-for-prima-facie-violation-of-undertaking-on-claims-ads/article67891696.ece |archive-date=27 February 2024 |language=en}}</ref>
 
In February 2024, the Supreme Court banned Patanjali's commercials and found Balkrishna in contempt. Patanjali was forced to apologize in newspapers by the Supreme Court. Patanjali apologized, but the court considered them insufficient. Patanjali issued more newspaper apologies per court ruling. The Uttarakhand Licensing Authority revoked 14 Patanjali product licenses after Supreme Court investigation of regulatory inaction.<ref>{{cite news |title=After Supreme Court rap, Patanjali issues another public apology — bigger in size |url=https://indianexpress.com/article/india/patanjali-second-public-apology-superme-court-ramdev-9287521/ |access-date=25 May 2024 |work=[[Indian Express]] |date=24 April 2024}}</ref><ref>{{cite news |title=Supreme Court not impressed with Uttarakhand authority's 'lightning' action to suspend 14 licences of Patanjali, Divya Pharmacy |url=https://www.thehindu.com/news/national/supreme-court-not-impressed-with-uttarakhand-authoritys-lightning-action-to-suspend-14-licences-of-patanjali-divya-pharmacy/article68124203.ece |access-date=25 May 2024 |work=[[The Hindu]] |date=30 April 2024}}</ref>
 
In August 2024, the Supreme Court closed contempt proceedings against Patanjali Ayurved co-founders Baba Ramdev and Acharya Balkrishna, and their company in the misleading advertisements case, accepting the apology tendered by the parties after they took steps to rectify their mistake. The top court, however, warned that both Ramdev and Balkrishna should comply with all future orders and not repeat their past conduct.<ref>{{Cite news |title=Supreme Court closes contempt case against Patanjali Ayurved, co-founders |url=https://www.business-standard.com/companies/news/supreme-court-closes-contempt-case-against-patanjali-ayurved-co-founders-124081301656_1.html}}</ref><ref>{{Cite news |title=Patanjali ads: Relief for Ramdev, Acharya Balakrishna as Supreme Court closes contempt case |url=https://www.hindustantimes.com/india-news/relief-for-ramdev-acharya-balakrishna-as-supreme-court-closes-patanjali-ads-contempt-case-101723526583723.html}}</ref>


==Products==
==Products==
 
Patanjali Ayurved produces cosmetics and personal-care, ayurvedic and food products.<ref>{{cite news|url=http://www.business-standard.com/article/companies/ramdev-turns-his-ayurved-enterprise-into-an-fmcg-empire-115062800143_1.html|title=Ramdev turns his Ayurved enterprise into an FMCG empire|date=28 June 2015}}</ref><ref name=indiatimes>{{cite news|url=http://indiatimes.com/news/india/here%E2%80%99s-why-baba-ramdev%E2%80%99s-200-crore-empire-is-making-corporate-india-uncomfortable-229410.html|title=Here's Why Baba Ramdev Is Making Corporate India Uncomfortable|publisher=Indiatimes|date=13 January 2015|access-date=14 January 2024|archive-date=15 January 2024|archive-url=https://web.archive.org/web/20240115064733/https://www.indiatimes.com/news/india/heres-why-baba-ramdevs-200-crore-empire-is-making-corporate-india-uncomfortable-229410.html|url-status=live}}</ref><ref>{{cite news|url=http://www.thehindubusinessline.com/news/states/we-plan-to-open-patanjali-outlets-at-rly-stations-airports-ramdev/article7231521.ece|title=We plan to open Patanjali outlets at Railway stations, airports: Ramdev|date=21 May 2015|access-date=20 June 2015|archive-date=15 January 2024|archive-url=https://web.archive.org/web/20240115064622/https://www.thehindubusinessline.com/news/national/|url-status=live}}</ref> The company opened Patanjali Paridhan, a clothing store in Delhi, in November 2018.<ref>{{cite news |last1=Saini |first1=Sonam |title=Patanjali's fashion foray: Baba Ramdev's company turns to apparel after creating ripples in FMCG |url=https://www.financialexpress.com/lifestyle/patanjalis-desi-fashion-vibes-after-creating-ripples-in-fmcg-ramdevs-company-turns-to-apparel/1490607/ |access-date=26 May 2021 |work=Financial Express |date=18 February 2019 |archive-date=15 January 2024 |archive-url=https://web.archive.org/web/20240115064617/https://www.financialexpress.com/lifestyle/patanjalis-desi-fashion-vibes-after-creating-ripples-in-fmcg-ramdevs-company-turns-to-apparel/1490607/ |url-status=live }}</ref>
[[File:Devanagari script used in product name.jpg|thumb|[[Toothpaste]] by Patanjali Ayurved]]
Patanjali Ayurved produces products in the categories of personal care, cosmetics, ayurvedic products, and food products.<ref>{{cite news|url=http://www.business-standard.com/article/companies/ramdev-turns-his-ayurved-enterprise-into-an-fmcg-empire-115062800143_1.html|title=Ramdev turns his Ayurved enterprise into an FMCG empire|date=28 June 2015}}</ref><ref name=indiatimes>{{cite news|url=http://indiatimes.com/news/india/here’s-why-baba-ramdev’s-200-crore-empire-is-making-corporate-india-uncomfortable-229410.html|title=Here's Why Baba Ramdev Is Making Corporate India Uncomfortable|publisher=Indiatimes|date=13 January 2015}}</ref><ref>{{cite news|url=http://www.thehindubusinessline.com/news/states/we-plan-to-open-patanjali-outlets-at-rly-stations-airports-ramdev/article7231521.ece|title=We plan to open Patanjali outlets at Railway stations, airports: Ramdev|date=21 May 2015}}</ref> In November 2018, the company started selling clothing, opening a store in Delhi under the name Patanjali Paridhan.<ref>{{cite news |last1=Saini |first1=Sonam |title=Patanjali's fashion foray: Baba Ramdev's company turns to apparel after creating ripples in FMCG |url=https://www.financialexpress.com/lifestyle/patanjalis-desi-fashion-vibes-after-creating-ripples-in-fmcg-ramdevs-company-turns-to-apparel/1490607/ |access-date=26 May 2021 |work=Financial Express |date=18 February 2019}}</ref>


==Sales and distribution==
==Sales and distribution==
Patanjali Ayurved sells through nearly 4,700 retail outlets as of May 2016.<ref name=indiatimes/><ref name="The Economic Times">{{cite news|date=13 January 2015|title=Baba Ramdev expands empire beyond yoga to FMCG|publisher=[[The Economic Times]]|url=http://articles.economictimes.indiatimes.com/2015-01-13/news/58024735_1_fmcg-business-fmcg-companies-patanjali-ayurved}}</ref> Patanjali also sells its products online and is planning to open outlets at [[Indian Railways|railway stations]] and [[List of airports in India|airports]].<ref name="India Today">{{Cite news|title=Ramdev's Patanjali Ayurved enters big retail with Future Group tie-up|publisher=India Today|url=http://indiatoday.intoday.in/story/ramdevs-patanjali-ayurved-enters-big-retail-with-future-group-tie-up/1/495151.html}}</ref> Patanjali Ayurveda has tied up with Pittie Group and [[Kishore Biyani]]'s [[Future Group]] on 9 October 2015.<ref name=indiatimes/> As per the tie-up with [[Future Group]], all the consumer products of Patanjali will be available for direct sale in [[Future Group]] outlets.<ref name="Nayi Duniya">{{cite news|date=9 October 2015|title=Ramdev products available in Big bazaar|publisher=Nayi Duniya|url=http://naidunia.jagran.com/business/commodity-baba-ramdev-signs-deal-with-future-group-503056}}</ref><ref name="Future group and Patanjali tie-up">{{cite news|date=9 October 2015|title=Future group and Patanjali tie-up|publisher=Patrika|url=http://www.patrika.com/news/industry/future-group-to-tie-up-with-baba-ramdev-s-patanjali-1117705}}</ref><ref name="The Hindu">{{cite news|date=9 October 2015|title=Future Group partners Patanjali Ayurveda|work=[[The Hindu]]|url=http://www.thehindu.com/business/Industry/future-group-shares-gain-on-tieup-with-ramdevs-patanjali/article7743470.ece}}</ref> Patanjali Ayurveda products are also available in modern trade stores including [[Reliance Industries|Reliance Retail]], [[HyperCity|Hyper City]] and Star Bazaar apart from online channels.<ref name=indiatimes/><ref name="Amar Ujala">{{cite news|date=18 December 2014|title=Patanjali products to be sold in Khadi bhandars|publisher=Amar Ujala|url=http://www.amarujala.com/feature/samachar/national/patanjali-prodocts-will-be-sold-on-khadi-bhandar-hindi-news-ss}}</ref><ref name="ABP Live">{{cite news|date=25 August 2015|title=Baba Ramdev's Patanjali Ayurveda to make, sell DRDO food products|publisher=ABP Live|url=http://www.abplive.in/india/2015/08/25/article694304.ece/Baba-Ramdevs-Patanjali-Ayurveda-to-make-sell-DRDO-food-products}}</ref><ref name="HuffPost India">{{cite news|date=24 August 2015|title=Baba Ramdev's Patanjali Ayurveda To Sell DRDO Food Products|publisher=HuffPost India|url=http://www.huffingtonpost.in/2015/08/24/ramdev-drdo_n_8029430.html}}</ref><ref name="thehindu.com">[http://www.thehindu.com/business/Industry/patanjali-ayurved-to-invest-rs-1150-crores/article8524025.ece] "Patanjali Ayurved to invest Rs 1,150 crores, eyes doubling revenue" The Hindu</ref> Patanjali Ayurved, co-founded by yoga guru [[Ramdev]], is targeting {{INRConvert|10000|c}} revenue in 2016–17, after-sales grew 150% in the previous financial year to {{INRConvert|5000|c}}.<ref>{{cite web|url=http://www.business-standard.com/article/companies/baba-ramdev-s-patanjali-aims-to-double-its-revenue-to-rs-10-000-cr-in-2016-17-116042700061_1.html|title=Baba Ramdev's Patanjali aims to double its revenue to Rs 10,000 cr in 2016-17|first=Arnab|last=Dutta|date=27 April 2016|access-date=16 March 2018|via=Business Standard}}</ref>
In May 2016, the company had nearly 4,700 retail outlets.<ref name="indiatimes" /><ref name="The Economic Times">{{cite news|date=13 January 2015|title=Baba Ramdev expands empire beyond yoga to FMCG|publisher=[[The Economic Times]]|url=http://articles.economictimes.indiatimes.com/2015-01-13/news/58024735_1_fmcg-business-fmcg-companies-patanjali-ayurved|access-date=18 January 2015|archive-date=10 May 2015|archive-url=https://web.archive.org/web/20150510204237/http://articles.economictimes.indiatimes.com/2015-01-13/news/58024735_1_fmcg-business-fmcg-companies-patanjali-ayurved|url-status=dead}}</ref> Patanjali also sells its products online, and is planning to open outlets at [[Indian Railways|railway stations]] and [[List of airports in India|airports]].<ref name="India Today">{{Cite news|title=Ramdev's Patanjali Ayurved enters big retail with Future Group tie-up|publisher=India Today|url=https://www.indiatoday.in/mail-today/story/ramdevs-patanjali-ayurved-enters-big-retail-with-future-group-tie-up-267388-2015-10-09}}</ref> The company joined Pittie Group and [[Kishore Biyani]]'s [[Future Group]] on 9 October 2015,<ref name=indiatimes/> making its products available in Future Group outlets.<ref name="Nayi Duniya">{{cite news|date=9 October 2015|title=Ramdev products available in Big bazaar|publisher=Nayi Duniya|url=https://www.naidunia.com/business/commodity-baba-ramdev-signs-deal-with-future-group-503056}}</ref><ref name="Future group and Patanjali tie-up">{{cite news|date=9 October 2015|title=Future group and Patanjali tie-up|publisher=Patrika|url=http://www.patrika.com/news/industry/future-group-to-tie-up-with-baba-ramdev-s-patanjali-1117705}}</ref><ref name="The Hindu">{{cite news|date=9 October 2015|title=Future Group partners Patanjali Ayurveda|work=[[The Hindu]]|url=http://www.thehindu.com/business/Industry/future-group-shares-gain-on-tieup-with-ramdevs-patanjali/article7743470.ece|access-date=14 October 2015|archive-date=15 January 2024|archive-url=https://web.archive.org/web/20240115064618/https://www.thehindu.com/business/Industry/future-group-shares-gain-on-tieup-with-ramdevs-patanjali/article7743470.ece|url-status=live}}</ref> Patanjali Ayurveda products are also available at [[Reliance Industries|Reliance Retail]], [[HyperCity|Hyper City]] and Star Bazaar.<ref name=indiatimes/><ref name="Amar Ujala">{{cite news|date=18 December 2014|title=Patanjali products to be sold in Khadi bhandars|publisher=Amar Ujala|url=http://www.amarujala.com/feature/samachar/national/patanjali-prodocts-will-be-sold-on-khadi-bhandar-hindi-news-ss}}</ref><ref name="ABP Live">{{cite news|date=25 August 2015|title=Baba Ramdev's Patanjali Ayurveda to make, sell DRDO food products|publisher=ABP Live|url=http://www.abplive.in/india/2015/08/25/article694304.ece/Baba-Ramdevs-Patanjali-Ayurveda-to-make-sell-DRDO-food-products}}</ref><ref name="HuffPost India">{{cite news|date=24 August 2015|title=Baba Ramdev's Patanjali Ayurveda To Sell DRDO Food Products|publisher=HuffPost India|url=http://www.huffingtonpost.in/2015/08/24/ramdev-drdo_n_8029430.html}}</ref><ref name="thehindu.com">[http://www.thehindu.com/business/Industry/patanjali-ayurved-to-invest-rs-1150-crores/article8524025.ece] {{Webarchive|url=https://web.archive.org/web/20240115065131/https://www.thehindu.com/business/Industry/patanjali-ayurved-to-invest-rs-1150-crores/article8524025.ece|date=15 January 2024}} "Patanjali Ayurved to invest Rs 1,150 crores, eyes doubling revenue" The Hindu</ref> The company had a target revenue of {{INRConvert|10000|c}} revenue in 2016–17, after sales increased by 150 percent in the previous financial year to {{INRConvert|5000|c}}.<ref>{{cite news|url=http://www.business-standard.com/article/companies/baba-ramdev-s-patanjali-aims-to-double-its-revenue-to-rs-10-000-cr-in-2016-17-116042700061_1.html|title=Baba Ramdev's Patanjali aims to double its revenue to Rs 10,000 cr in 2016-17|first=Arnab|last=Dutta|newspaper=Business Standard India|date=27 April 2016|access-date=16 March 2018|via=Business Standard}}</ref>


Patanjali Ayurved has also started its [[Fast-moving consumer goods|FMCG]] expansion in form of dealership and distributorship channels across the country and expects wider growth in overseas distribution as well.<ref name="CDN Times">{{cite news|date=21 November 2016|title=Patanjali Ayurved Ltd Distributorship and Dealership process online|publisher=CDN Times|url=http://www.cdntimes.com/2016/05/patanjali-products-distributorship-online.html}}</ref>
Patanjali Ayurved's advertisement and sales promotion expenses in FY24 rose by 145.46% compared to FY23, increasing from Rs 173.13 crore to Rs 424.7 crore<ref>{{Cite web |last=bureau |first=afaqs! news |date=2024-09-05 |title=Patanjali's ad spends increase by 145% YoY to Rs 424.7 crore in FY2024 |url=https://www.afaqs.com/news/advertising/patanjalis-ad-spends-increase-by-145-to-rs-4247-crore-in-fy2024?utm_source=mailer&utm_medium=eveninger-Sep-5-2024&utm_campaign=eveninger-news/advertising/patanjalis-ad-spends-increase-by-145-to-rs-4247-crore-in-fy2024-newsletter-Sep-5-2024 |access-date=2024-09-05 |website=afaqs! |language=en}}</ref>


==Acquisition==
==Acquisition==
In December 2019, Patanjali acquired bankrupt [[Ruchi Soya|Ruchi Soya Industries]] at a valuation of {{INRConvert|4350|c}}. At present, Ruchi Soya is a mid-cap company listed on NSE and BSE in India. It's a major soybean product player in India.<ref>{{Cite web|title=Patanjali Completes Acquisition Of Ruchi Soya|url=https://www.bloombergquint.com/business/patanjali-completes-acquisition-of-ruchi-soya|website=BloombergQuint|language=en|access-date=2020-05-02}}</ref>
In December 2019, Patanjali reportedly acquired bankrupt [[Ruchi Soya|Ruchi Soya Industries]] for {{INRConvert|4350|c}}.<ref>{{Cite web|title=Patanjali Completes Acquisition Of Ruchi Soya|url=https://www.bloombergquint.com/business/patanjali-completes-acquisition-of-ruchi-soya|website=BloombergQuint|date=18 December 2019 |language=en|access-date=2020-05-02|archive-date=15 January 2024|archive-url=https://web.archive.org/web/20240115065132/https://www.ndtvprofit.com/business/patanjali-completes-acquisition-of-ruchi-soya|url-status=live}}</ref>


==See also==
==See also==
* [[Acharyakulam]]
*[[FMCG in India]]
* [[Bharat Swabhiman Trust]]
* [[Patanjali Yogpeeth]]
* [[Yog Gram]]


==References==
==References==
{{Reflist|40em}}
{{Reflist|20em}}


==External links==
==External links==
*{{official}}
*{{official website}}


[[Category:2006 establishments in Uttarakhand]]
[[Category:Ayurvedic companies]]
[[Category:Ayurvedic companies]]
[[Category:Food and drink companies of India]]
[[Category:Companies based in Uttarakhand]]
[[Category:Companies based in Uttarakhand]]
[[Category:Food and drink companies established in 2006]]
[[Category:Food and drink companies established in 2006]]
[[Category:2006 establishments in Uttarakhand]]
[[Category:Food and drink companies of India]]
[[Category:Ramdev]]
[[Category:Indian brands]]
[[Category:Indian brands]]
[[Category:Pharmaceutical industry of India]]
[[Category:Patanjali Ayurved]]
[[Category:Patanjali Ayurved]]
[[Category:Pharmaceutical industry in India]]
[[Category:Ramdev]]
[[Category:Multinational companies headquartered in India]]

Latest revision as of 17:20, 19 February 2026


Patanjali Ayurved
IndustryConglomerate
Founded2006; 20 years ago (2006)
Founder(s)
Headquarters,
India
Area served
[1]
Key people
Balkrishna
(chairperson, managing director & CEO)
Products
RevenueIncrease9,872 crore (US$1.4 billion) (2021)[2]
Increase485 crore (US$68 million) (2021)[2]
OwnerBalkrishna (94%)
Number of employees
6,395 (November 2023)[3]
Subsidiaries
Website{{URL|example.com|optional display text}}

Patanjali Ayurved is an Indian multinational conglomerate holding company, based in Haridwar. It was founded by Ramdev and Balkrishna in 2006.[5] Its office is in Delhi, with manufacturing units and headquarters in the industrial area of Haridwar.[6] The company manufactures cosmetics, ayurvedic medicine, personal care and food products.[7] The CEO of the company, with a 94-percent share hold, is Balkrishna. Ramdev represents the company and makes strategic decisions.[8][9][10] The company has faced various controversies over its misleading promotions and false claims for COVID-19 treatment.[11]

History[edit | edit source]

Ramdev and Balkrishna established Patanjali Ayurved in 2006.[5][12][13] Balkrishna owns 94 percent of the company, and the remainder is dispersed among other individuals.[9] In May 2021, Balkrishna had a net worth of US$2.3 billion.[14]

According to CLSA and HSBC, Patanjali was one of the fastest-growing FMCG companies in India in 2016. It was valued at 3,000 crore (equivalent to 35 billion or US$490 million in 2019).[15][16][17] Patanjali estimated its annual turnover for the 2016–17 fiscal year at 10,216 crore (US$1.4 billion).[18] According to a report by India Infoline (IIFL), at least 13 listed companies would be affected by Patanjali's success; they included Hindustan Unilever, Colgate, Dabur, ITC, and Godrej Consumer Products.[17]

In 2025, Patanjali Ayurved along with DS Group acquired Magma General Insurance for ₹4,500 crore. [19]

In December 2025, The Government of Tripura partnered with Patanjali Ayurved for a project in Tripura State worth Rs 300-400 crores.[20]

Patanjali Ayurved opened a hospital "Patanjali Emergency & Critical Care Hospital" on 22nd January 2026 which was inaugurated by home minister of India Amit Shah.[21]

Revenue[edit | edit source]

Year Revenue

in crores

2010–11 ₹1000
2011–12 ₹300
2012–13 ₹841
2013–14 ₹1,184
2014–15 ₹2,006
2015–16 ₹8,000
2016–17 ₹10,526[22]
2017–18 ₹9,500[23]
2018–19 ₹8,330[24]

Future Group, which has joined with Patanjali, sells about 30 crore (US$4.2 million) worth of Patanjali products every month.[25][26][27]

Production[edit | edit source]

Patanjali Food and Herbal Park in Haridwar is the company's main production facility. With a production capacity of 35,000 crore (equivalent to 380 billion or US$5.3 billion in 2019), it is expanding to a capacity of 60,000 crore (equivalent to 690 billion or US$9.7 billion in 2019) through new production units in Noida, Nagpur, and Indore.[23][28][29]

In 2016, the Patanjali Food and Herbal Park received 35 full-time, armed Central Industrial Security Force (CISF) commandos.[30][31][32] The park will be the eighth private institute in India to be guarded by paramilitary CISF forces.[32]

Controversies[edit | edit source]

Patanjali Ayurved has had many cases filed against by the Government of Uttarakhand for various offences[33]

In June 2025, The Nainital High Court has quashed the criminal case against Patanjali Ayurveda Limited and its founders Baba Ramdev and Acharya Balkrishna for publishing misleading advertisements.[34]

Patanjali has been cited for its working conditions; Ramdev and Balkrishna are treated as gurus whose feet must be touched each time they enter an area. Workers are paid 6,000 (US$84) per month, working 12-hour shifts, six days a week.[35][36] They are also discouraged from asking for a raise, with the rationale that working at the factory is considered "seva" (voluntary service) to the cause and is a payment in itself.[36][37][38] On 22 May 2021, the Indian Medical Association (IMA) in Uttarakhand sent a defamation notice of 1,000 crore (US$140 million) after remarks by Ramdev about doctors who practise evidence-based medicine.[39][40]

Infertility cure[edit | edit source]

One of the products manufactured by Ramdev's Divya pharmacy and sold by the Patanjali Pharmacy chain was Divya Putrajeevak Seed, described in its catalog as a natural herb which (according to the company) could treat infertility. However, doctors pointed out the misleading name of the drug: the word "putrajeevak" (lit. transl. "son's life" ). Some Patanjali Pharmacy stores sold the drug with the claim that it would ensure the birth of a boy, reportedly leading to an increase in sales.[41]

The issue was raised in the Indian Parliament in July 2015 by opposition members who accused Ramdev of "peddling a product which promised delivery of male children." The Ministry of AYUSH (which oversees the sale of alternative medicines) defended the product's name, saying that it was named after a herb.[42]

In 2016, the Uttarakhand health department said that the drug violated the Pre-Conception and Pre-Natal Diagnostic Techniques Act, 1994.[43] The Maharashtra government ordered a probe of whether the drug had violated laws in 2018, and Congress leaders in the state demanded a ban on the drug.[44]

Ganges pollution[edit | edit source]

In January 2018, villages in Haridwar district complained that Patanjali's Padarth factory was polluting a Ganges channel and other local rain-fed bodies of water with surface runoff; chemicals released by the factory reportedly killed several animals in the area. The local government took no action on the factory due to Ramdev's influence, and residents of 40 villages threatened agitation.[45] The Uttarakhand Environment Conservation and Pollution Control Board ordered a clean-up of the waste flowing through the area. In the past, the board had notified Padarth about its release of untreated industrial effluent into local bodies of water. Patanjali's general manager denied the allegations, saying that the company followed established protocols.[45]

Amla juice[edit | edit source]

The Ministry of Defence canteen stores department (CSD) suspended Patanjali Ayurved's amla juice after receiving an adverse state laboratory test report on the product; the central food laboratory found the juice unfit for consumption. The CSD asked its depots to make debit notes for their existing stock, so the product could be returned.[46][35][47][48]

FSSAI notices[edit | edit source]

Patanjali introduced its instant noodles on 15 November 2015.[49][50][51] The Food Safety and Standards Authority of India notified the company that neither Patanjali nor Aayush, the brand names for which Patanjali obtained licenses, received approval for the manufacture of instant noodles.[52][53][54][55] In Rajasthan, mustard oil sold by Patanjali was found substandard by the FSSAI's Alwar laboratory.[56]

Ayush Ministry against false advertisements[edit | edit source]

Ministry of AYUSH has advised certain states to take necessary action against Baba Ramdev's Patanjali Ayurved for illegally promoting products that claimed to cure diabetes, heart and liver diseases. The Ministry has specifically sought action against the advertisements of three Patanjali products — Lipidom, Livogrit and Livamrit.[57][58][59]

Fake COVID-19 treatment[edit | edit source]

Patanjali Ayurved announced a drug named Coronil for COVID-19 treatment in June 2020, with Ramdev claiming that it cured the disease.[60][61][11] There was no clinical data to prove that the new drug was effective or even safe; this prompted a social-media backlash which questioned the role of the Ministry of AYUSH.[62] Within hours of Coronil's introduction, the ministry issued a statement denying authorisation for the new drug and asking the company to stop selling (and advertising) it until the trial results were examined by medical authorities.[63][64][65] An official from the ayurved department of the government of Uttarakhand said that the approval application for Coronil had not mentioned COVID-19.[66]

Laboratory tests showed that the drug did not contain any ingredients which could treat or prevent coronavirus infections. The Indian government allowed Patanjali Ayurved to market Coronil as an immunity booster (not a cure),[11] but the Government of Maharashtra has banned the sale of Coronil in the state. First information reports were filed in Bihar and Rajasthan against Ramdev, Balkrishna and others, accusing them of dishonesty and selling fake medicines.[67][68] Patanjali responded to the accusations, saying that they did not violate any procedures before the drug was launched.[69] A Madras High Court judge fined the company 1,000,000 (US$14,000) for making false claims about the drug, and Patanjali withdrew its claim that Coronil could cure COVID-19. The UK drug regulator threatened action if unauthorized products were sold in the UK.[11]

The government of Maharashtra banned Coronil in the state in June 2020, with home minister Anil Deshmukh threatening the company with legal action if they did not observe the ban.[70] The Madras High Court also barred Patanjali Ayurved from using the name "Coronil".[71][72] The court's order came while it heard a suit filed by a Chennai-based firm which said that it had owned the trademark "Coronil" since 1993. Making an earlier interim injunction against Patanjali absolute, Madras High Court Justice C. V. Karthikeyan also imposed the fine on the company.[73][74] In his ruling, the judge observed that Patanjali had been "chasing further profits by exploiting the fear and panic among the general public by projecting a cure for the coronavirus when their 'Coronil Tablet' is not a cure".[75][71][76] Nepal and Bhutan halted the distribution of donated Coronil after orders from their governments to disclose that it was not a medicine to cure COVID-19.[77][78]

False claims of government and WHO approvals[edit | edit source]

In February 2021, The Indian Express, The Times of India, The Hindu and Livemint reported Patanjali Ayurved's claim that Coronil had been approved by the Ministry of AYUSH and certified by the World Health Organization. The reports indicated that Ramdev had released studies showing that Coronil was effective against COVID-19 at a press conference attended by Union Health Minister Harsh Vardhan and transport minister Nitin Gadkari.[79][80][81][82] In a News Nation interview, Ramdev accused doctors of "allopathic terrorism" for doubting Coronil's effectiveness.[83] The claim was endorsed by Bharatiya Janata Party spokesperson Sanju Verma, who called it "... a huge endorsement for Ayurveda India's homegrown StartUp ecosystem that has flourished under @narendramodi govt."[83] Verma described the approvals granted to Coronil as a "slap in the face" to the BJP's opposition.[84]

On 22 February, the WHO said that it had not "... reviewed or certified the effectiveness of any traditional medicine for the treatment #Covid19."[85] Several news and fact-checking outlets, including The Wire, Alt News, BBC News and The Economic Times, ran fact-checking articles debunking Ramdev and Patanjali's claims; Coronil had received an export license, and had not received any approval regarding its effectiveness as a treatment against COVID-19.[86][87][83][88] Patanjali Ayurveda CEO Balkrishna admitted on Twitter that the approval for Coronil had not come from the WHO or the Ministry of AYUSH (as they had claimed), but had been granted by the Drugs Controller General of India for export – not as a certification of effectiveness.[83][86]

Taking control over Dalits' lands[edit | edit source]

In August 2022, Newslaundry published a report alleging that Patanjali took control of Dalits' lands for cow shelter and herb farms in Teliwala village, Uttarkhand through force and circumvention of laws, making people there landless.[89] With their land in control of Patanjali, Dalits have no choice other than working for the company or migrating elsewhere for finding employment.

Accusations of using fish bones in veg product[edit | edit source]

In May 2023, a Delhi-based law firm issued a legal notice to Patanjali Ayurved accusing the company of using 'cuttlefish bones' in dental care product, branding non-veg product as vegetarian in violation of the law.[90]

Misleading advertising case[edit | edit source]

The company has been accused of misleading advertising[91][92] about its products and flimsy testing before being marketed.[93] Between April 2015 and July 2016, 33 complaints were received against 21 misleading advertisements; seventeen violated ASCI standards.[94] In September 2017, the Delhi High Court ordered the company to stop airing an advertisement for its brand of chyavanprash which disparaged a competitor's.[95] Company products, such as amla juice[46][35] and ayurvedic medicines[96] have been banned for poor quality.[35][47]

Patanjali was sued by the Indian Medical Association in August 2022 for attacking allopathy to promote its medicines, violating DOMA and the Consumer Protection Act, 2019. The Supreme Court accused Patanjali of misleading marketing in November 2023 and threatened a Rs 1 crore per product fine for bogus promises.[97][98]

In February 2024, the Supreme Court banned Patanjali's commercials and found Balkrishna in contempt. Patanjali was forced to apologize in newspapers by the Supreme Court. Patanjali apologized, but the court considered them insufficient. Patanjali issued more newspaper apologies per court ruling. The Uttarakhand Licensing Authority revoked 14 Patanjali product licenses after Supreme Court investigation of regulatory inaction.[99][100]

In August 2024, the Supreme Court closed contempt proceedings against Patanjali Ayurved co-founders Baba Ramdev and Acharya Balkrishna, and their company in the misleading advertisements case, accepting the apology tendered by the parties after they took steps to rectify their mistake. The top court, however, warned that both Ramdev and Balkrishna should comply with all future orders and not repeat their past conduct.[101][102]

Products[edit | edit source]

Patanjali Ayurved produces cosmetics and personal-care, ayurvedic and food products.[103][104][105] The company opened Patanjali Paridhan, a clothing store in Delhi, in November 2018.[106]

Sales and distribution[edit | edit source]

In May 2016, the company had nearly 4,700 retail outlets.[104][107] Patanjali also sells its products online, and is planning to open outlets at railway stations and airports.[108] The company joined Pittie Group and Kishore Biyani's Future Group on 9 October 2015,[104] making its products available in Future Group outlets.[109][110][111] Patanjali Ayurveda products are also available at Reliance Retail, Hyper City and Star Bazaar.[104][112][113][114][115] The company had a target revenue of 10,000 crore (US$1.4 billion) revenue in 2016–17, after sales increased by 150 percent in the previous financial year to 5,000 crore (US$700 million).[116]

Patanjali Ayurved's advertisement and sales promotion expenses in FY24 rose by 145.46% compared to FY23, increasing from Rs 173.13 crore to Rs 424.7 crore[117]

Acquisition[edit | edit source]

In December 2019, Patanjali reportedly acquired bankrupt Ruchi Soya Industries for 4,350 crore (US$610 million).[118]

See also[edit | edit source]

References[edit | edit source]

  1. "Patanjali to launch 'Swadeshi' jeans soon, exploring global markets with FMCG". Firstpost. 12 September 2016. Archived from the original on 7 May 2023. Retrieved 4 December 2016.
  2. 2.0 2.1 "Patanjali Ayurved clocked 14% jump in profit in FY21: Tofler data". 2023.
  3. "Patanjali Ayurved". Tracxn. 4 May 2024. Retrieved 9 May 2024.
  4. "Patanjali CEO Acharya Balkrishna Among India's Richest: ChaMagazine". NDTV. NDTV. 18 September 2016. Archived from the original on 27 September 2022. Retrieved 10 January 2017.
  5. 5.0 5.1 Bahree, Megha (26 October 2016). "India's Baba Ramdev Billionaire Is Not Baba Ramdev". Forbes. Retrieved 16 February 2017.
  6. Aradhak, Purusharth. "430 acres allotted to Patanjali". The Hindu. Archived from the original on 20 January 2023. Retrieved 26 February 2017.
  7. Worth, Robert F. (26 July 2018). "The Billionaire Yogi Behind Modi's Rise". The New York Times. ISSN 0362-4331. Archived from the original on 5 June 2023. Retrieved 13 July 2021.
  8. Vyas, Jwalit (29 February 2016), "Baba Ramdev's Patanjali starts to take a toll on some FMCG firms", The Economic Times
  9. 9.0 9.1 "Baba Ramdev is just the face, it's Acharya Balakrishna who is behind Patanjali's Rs 10,561 cr turnover". Business Today. 4 May 2017. Archived from the original on 3 October 2020. Retrieved 30 May 2021.
  10. Findlay, Stephanie; Singh, Jyotsna (6 August 2020). "India's yogi tycoon angers critics with coronavirus 'cure' kit". Financial Times.
  11. 11.0 11.1 11.2 11.3 "Covid-19: Fake 'immunity booster' found on sale in London shops". BBC News. 19 December 2020. Archived from the original on 15 January 2024. Retrieved 21 December 2020.
  12. "Baba Ramdev's Business Empire Soars, With His Own Rising Profile". HuffPost India. Archived from the original on 4 May 2015. Retrieved 18 January 2015.
  13. Rakshit, Avishek (8 February 2016). "The Patanjali effect". Business-Standard.
  14. "Forbes profile: Acharya Balkrishna". Forbes. Retrieved 30 May 2021.
  15. "Are PEs bending over backwards to invest in Patanjali?". The Hindu. 11 January 2016.
  16. "Patanjali is disrupting India's consumer space". IIFL. 6 February 2016. Archived from the original on 17 May 2022. Retrieved 7 February 2016.
  17. 17.0 17.1 "HSBC Global Rsearch cuts target prices of Britannia Dabur and Nestle between 6% and 16%, says Patanjali". Economic Times. 5 February 2016. Archived from the original on 23 May 2022. Retrieved 7 February 2016.
  18. Arnab Dutta (5 May 2017). "Ramdev's Patanjali shakes up FMCG order; next up 'nutritious restaurants'". Business Standard. Archived from the original on 15 July 2017. Retrieved 15 July 2017.
  19. "Patanjali Ayurved, DS Group to acquire Magma General Insurance for ₹4,500 crore". The Hindu. 13 March 2025.
  20. "Tripura government sign MOU with Patanjali Ayurved for project in Tripura". tripurainfo DOT com.
  21. "Patanjali launches India's first hybrid hospital for heart, brain and spine care". The Times of India. 22 January 2026.
  22. "Patanjali sales growth grinds to a halt in FY18", Livemint, 18 May 2018
  23. 23.0 23.1 "Patanjali and its grand plans: Ramdev expects Rs 20,000 cr revenue in FY18", Business Standard, Press Trust of India, 4 May 2017
  24. "Patanjali reports Rs 8,339 crore revenue in FY 19; food items account for 62% of total sales", Business Today, 19 November 2019, archived from the original on 15 January 2024, retrieved 20 December 2019
  25. "Baba Ramdev's Patanjali Group compels FMCG firms Hindustan Unilever and Dabur to expand portfolio". IBT Times. 26 January 2016. Archived from the original on 15 January 2024. Retrieved 7 February 2016.
  26. http://www.india.com/news/india/patanjali-ayurved-doubles-its-profit-in-one-year-set-to-catch-up-with-rivals-1051546/ Archived 15 January 2024 at the Wayback Machine Patanjali Ayurved doubles its profit in one year; set to catch up with rivals
  27. Mitra, Sounak (3 June 2016). "Inside Baba Ramdev's Patanjali empire". livemint. Archived from the original on 15 January 2024. Retrieved 18 December 2022.
  28. "Ramdev to open herbal factory in Nepal". Web Dunia. 18 April 2015.
  29. "Patanjali herbal park in Nepal". Insight TV News Network. 28 February 2015. Archived from the original on 2 April 2015. Retrieved 29 October 2015.
  30. Yadav, Yatish (9 March 2016). "CISF Team to Guard Ramdev's Food Park". NEW DELHI: Indian Express. Archived from the original on 9 March 2016.
  31. Sharma, Varun (8 March 2016). "Ramdev's Food Park Gets Round-The-Clock Protection From Paramilitary CISF". NDTV. Archived from the original on 15 January 2024. Retrieved 9 March 2016.
  32. 32.0 32.1 "Ramdev's food park gets full-time CISF cover". The Tribune India. 9 March 2016.[permanent dead link]
  33. Prashant, Shishir (20 March 2017). "With BJP in power, focus is now on cases against Baba Ramdev". Business Standard India. Retrieved 21 December 2020.
  34. "Uttarakhand News: पतंजलि, बाबा रामदेव और आचार्य बालकृष्ण के खिलाफ आपराधिक मामला रद्द, जानिये मामला". Amar Ujala (in हिन्दी).
  35. 35.0 35.1 35.2 35.3 "Military Canteens Ban sales of Patanjali Amla Juice". Saying Truth. 24 April 2017. Archived from the original on 15 January 2024. Retrieved 7 October 2020.
  36. 36.0 36.1 "Baba Ramdev: Inside Patanjali: Here's what life is like in Baba Ramdev's company". The Economic Times. Archived from the original on 15 January 2024. Retrieved 10 October 2022.
  37. Pathak-Narain, Priyanka (4 August 2017). "Patanjali believes its staff does 'seva': Ex-CEO S.K. Patra". mint. Archived from the original on 15 January 2024. Retrieved 10 May 2021.
  38. "Baba Ramdev wants employees to work for free: A former CEO reveals the Patanjali story". The New Indian Express (newspaper). 4 August 2017. Archived from the original on 18 April 2021.
  39. "'Criminal act': Ramdev gets ₹1,000 cr defamation notice from IMA Uttarakhand". Hindustan Times. 26 May 2021. Archived from the original on 15 January 2024. Retrieved 26 May 2021.
  40. "IMA Uttarakhand sends Rs 1,000-cr defamation notice to Ramdev over remarks on allopathy". www.businesstoday.in. 26 May 2021. Archived from the original on 15 January 2024. Retrieved 26 May 2021.
  41. "In Name of Ramdev's Infertility Cure, the Promise of a Boy Child?". NDTV.com. Retrieved 21 December 2020.
  42. "Ramdev's 'Putrajeevak beej' is named after herb: AYUSH minister". Business Standard India. 26 May 2015. Retrieved 21 December 2020.
  43. Azad, Shivani (2 February 2018). "U'khand says Ramdev's fertility pill 'Putrajeevak Beej' violates PNDT Act". The Times of India. TNN. Retrieved 21 December 2020.
  44. Naik, Yogesh (21 July 2018). "Govt to probe sale of controversial Patanjali product". Mumbai Mirror. Retrieved 21 December 2020.
  45. 45.0 45.1 "Villagers say Patanjali unit polluting water bodies in Haridwar". Hindustan Times. 23 January 2018. Retrieved 21 December 2020.
  46. 46.0 46.1 Dangwal, Sandhya (24 April 2017). "CSD withdraws Baba Ramdev's popular product after lab declares it unfit for consumption". India News, Breaking News, Entertainment News | India.com. Archived from the original on 15 January 2024. Retrieved 7 October 2020.
  47. 47.0 47.1 "Ramdev's Patanjali products fail quality test, RTI inquiry finds". Hindustan Times. 30 May 2017. Archived from the original on 15 January 2024. Retrieved 21 December 2020.
  48. "Defence canteens remove Ramdev's Patanjali amla juice after adverse lab report". Archived from the original on 15 January 2024. Retrieved 18 May 2020.
  49. "Ramdev's Patanjali launches noodles". The Hindu. 16 November 2015. Archived from the original on 15 January 2024. Retrieved 19 November 2015.
  50. "FSSAI sends notice to Baba Ramdev's company". ibnlive.com. 21 November 2015.
  51. "Trouble mounts for Ramdev's Atta Noodles, FSSAI issues notice to Patanjali Ayurved". Navbharat Times.
  52. "No Approval for Patanjali Instant Noodles, Says Food Safety Regulator". NDTV. 18 November 2015.
  53. "'No licence for noodles': FSSAI slaps showcause on Patanjali". The Indian Express. 21 November 2015.
  54. "Patanjali's Atta Noodles in trouble: Baba Ramdev breaks silence, drags Modi govt into controversy". oneindia.com. 19 November 2015.
  55. "Patanjali Atta noodles gets notice". livehindustan.com. Archived from the original on 26 November 2015. Retrieved 13 January 2016.
  56. Sharat Kumar (10 June 2021). "Patanjali mustard oil found to be of substandard food quality: Rajasthan govt". India Today. Archived from the original on 15 January 2024. Retrieved 30 June 2021.
  57. "Patanjali ads claiming to cure heart, liver issues come under govt scanner". The News Minute. 27 April 2022. Archived from the original on 15 January 2024. Retrieved 28 April 2022.
  58. "AYUSH Ministry seeks action against advertisements by Ayurveda pharma". The Hindu. 24 April 2022. ISSN 0971-751X. Archived from the original on 15 January 2024. Retrieved 28 April 2022.
  59. "Glare on Patanjali for heart and liver products advertisements". www.telegraphindia.com. Archived from the original on 15 January 2024. Retrieved 28 April 2022.
  60. Kumar, Ravi Prakash (23 June 2020). "Coronavirus treatment: Ramdev's Patanjali launches Coronil kit for ₹545". Livemint. Archived from the original on 15 January 2024. Retrieved 24 June 2020.
  61. "Baba Ramdev's Patanjali launches Ayurvedic medicine Coronil for coronavirus! All you need to know". The Financial Express. 23 June 2020. Archived from the original on 15 January 2024. Retrieved 24 June 2020.
  62. Narayanan, Kavya (28 June 2020). "AYUSH Ministry is endangering people, jeopardising Ayurveda with lax response to Patanjali's Coronil and COVID-19, warn experts". Firstpost. Archived from the original on 21 November 2020. Retrieved 29 June 2020.
  63. "Govt asks Patanjali to stop ads of Covid drug". Hindustan Times. 23 June 2020. Archived from the original on 15 January 2024. Retrieved 24 June 2020.
  64. "Ramdev's Patanjali Asked By Government To Explain COVID Drug Claim". NDTV.com. Archived from the original on 15 January 2024. Retrieved 24 June 2020.
  65. "Ayush Ministry Stops Patanjali From Selling, Advertising Purported Covid Medicine". BloombergQuint. 23 June 2020. Archived from the original on 15 January 2024. Retrieved 24 June 2020.
  66. "Patanjali's Coronil approval application did not mention coronavirus: Licence officer". India Today. 24 June 2020. Archived from the original on 15 January 2024. Retrieved 29 June 2020.
  67. Afreen, Jasra (29 June 2020). "Complaint filed in Bihar court against Baba Ramdev over Covid-19 medicine claim". Hindusthan Times. Archived from the original on 15 January 2024. Retrieved 29 June 2020.
  68. "FIR against 5 over Covid-19 'medicine' claim: Ramdev, Patanjali MD booked for 'cheating'". Indian Express. 29 June 2020. Archived from the original on 15 January 2024. Retrieved 29 June 2020.
  69. Sahay, Abhinav (24 June 2020). "'All parameters met': Patanjali claims Coronil clinical trial details furnished to Centre". Hindusthan Times. Archived from the original on 15 January 2024. Retrieved 29 June 2020.
  70. Shrivastava, Sonu (26 June 2020). "Maharashtra bans Patanjali's COVID-19 medicine 'Coronil'". Asian Age. Archived from the original on 15 January 2024. Retrieved 29 June 2020.
  71. 71.0 71.1 Mandhani, Apoorva (6 August 2020). "Patanjali can't use Coronil trademark, says Madras High Court, fines it Rs 10 lakh". ThePrint. Archived from the original on 15 January 2024. Retrieved 18 February 2021.
  72. Lobo, Shalini (6 August 2020). "Patanjali chased profits by exploiting public fear: Madras HC imposes Rs 10 lakh fine on firm". India Today. Archived from the original on 15 January 2024. Retrieved 18 February 2021.
  73. "Madras HC: Patanjali cannot use 'Coronil' branding, must pay Rs 10 lakh fine for exploiting fear". cnbctv18.com. 6 August 2020. Archived from the original on 15 January 2024. Retrieved 18 February 2021.
  74. "Patanjali exploited public fear says Madras HC, imposes Rs 10 lakh fine". The News Minute. 6 August 2020. Archived from the original on 15 January 2024. Retrieved 18 February 2021.
  75. "Patanjali Ayurved fined Rs 10 lakh by Madras HC for chasing profits by claiming COVID-19 'cure'". The New Indian Express. 6 August 2020. Archived from the original on 15 January 2024. Retrieved 18 February 2021.
  76. "Patanjali Fined Rs 10 Lakh by Madras HC for Chasing Profits amid Covid-19 Fear, Using Coronil Trademark". News18. 6 August 2020. Archived from the original on 15 January 2024. Retrieved 18 February 2021.
  77. Bhattacherjee, Kallol (8 June 2021). "Nepal stops distribution of Coronil kits gifted by Patanjali". The Hindu. ISSN 0971-751X. Archived from the original on 15 January 2024. Retrieved 30 June 2021.
  78. Geeta Mohan (9 June 2021). "Nepal stops distribution of Coronil kits gifted by Patanjali, cites lack of proof on efficacy". India Today. Archived from the original on 15 January 2024. Retrieved 30 June 2021.
  79. "Coronil has received AYUSH certification as per WHO norms: Patanjali". The Indian Express. 20 February 2021. Archived from the original on 19 February 2021. Retrieved 21 February 2021.
  80. "Coronil has received Ayush Ministry certification as per WHO scheme: Patanjali". mint. 19 February 2021. Archived from the original on 19 February 2021. Retrieved 21 February 2021.
  81. "Patanjali Coronil: Coronil gets Ayush ministry certification as per WHO scheme: Patanjali". The Times of India. 19 February 2021. Archived from the original on 20 February 2021. Retrieved 21 February 2021.
  82. "Coronil gets Ayush Ministry certification as 'supporting measure' for COVID-19 treatment". The Hindu. PTI. 19 February 2021. ISSN 0971-751X. Archived from the original on 15 January 2024. Retrieved 21 February 2021.
  83. 83.0 83.1 83.2 83.3 Chaudhuri, Pooja (21 February 2021). "Fact Check: Patanjali's Coronil Neither WHO Certified nor Approved". The Wire Science. Archived from the original on 15 January 2024. Retrieved 21 February 2021.
  84. "Tweet: @Sanju_Verma". Twitter. 19 February 2021.
  85. Awasthi, Prashasti (21 February 2021). "WHO clarifies it hasn't reviewed or certified Coronil for Covid-19 treatment". @businessline. Retrieved 21 February 2021.
  86. 86.0 86.1 Bhushan, Ratna. "Patanjali's Coronil not WHO certified or approved; no traditional medicine certified by WHO for Covid cure". The Economic Times. Retrieved 21 February 2021.
  87. "Patanjali's Coronil is neither WHO certified nor approved, media outlets run false news". Alt News. 20 February 2021. Archived from the original on 15 January 2024. Retrieved 21 February 2021.
  88. Menon, Shruti (2 March 2021). "Coronavirus: The misleading claims about an Indian remedy". BBC Reality Check. Archived from the original on 15 January 2024. Retrieved 26 May 2021.
  89. Kumar, Basant (19 August 2022). "How Ramdev's Patanjali took control of Dalit lands in Haridwar". Newslaundry. Archived from the original on 15 January 2024. Retrieved 31 August 2022.
  90. Dutta, Sumi Sukanya (18 May 2023). "Patanjali gets legal notice for using 'cuttlefish bones' in dental care product marked vegetarian". ThePrint. Archived from the original on 15 January 2024. Retrieved 18 May 2023.
  91. "Patanjali Advertisements Unsubstantiated, Misleading: Watchdog". NDTV.com. 4 July 2016. Archived from the original on 15 January 2024. Retrieved 2 May 2021.
  92. "Patanjali Ayurved Rapped For Misleading Hair Oil, Other Advertisements". NDTV.com. 26 May 2016. Archived from the original on 15 January 2024. Retrieved 2 May 2021.
  93. "Ramdev's Patanjali products fail quality test, RTI inquiry finds". Hindustan Times. 29 May 2017. Archived from the original on 15 January 2024. Retrieved 7 October 2020.
  94. "33 Complaints Received Against Patanjali Advertisements". NDTV.com. 2 August 2016. Archived from the original on 15 January 2024. Retrieved 2 May 2021.
  95. "Delhi Court Restrains Patanjali From Airing Ads Promoting Chyawanprash". NDTV.com. 7 September 2017. Archived from the original on 11 September 2017. Retrieved 2 May 2021.
  96. "Nepal drug administration reject six Patanjali products after tests, contain pathogenic bacteria". Firstpost. 22 June 2017. Archived from the original on 15 January 2024. Retrieved 7 October 2020.
  97. Kalia, Saumya (3 March 2024). "Supreme Court's ban on Patanjali ads | Explained". The Hindu. Retrieved 25 May 2024.
  98. Rajagopal, Krishnadas (27 February 2024). "Supreme Court issues contempt notice to Patanjali, its MD Balkrishna". The Hindu. Archived from the original on 27 February 2024. Retrieved 28 February 2024.
  99. "After Supreme Court rap, Patanjali issues another public apology — bigger in size". Indian Express. 24 April 2024. Retrieved 25 May 2024.
  100. "Supreme Court not impressed with Uttarakhand authority's 'lightning' action to suspend 14 licences of Patanjali, Divya Pharmacy". The Hindu. 30 April 2024. Retrieved 25 May 2024.
  101. "Supreme Court closes contempt case against Patanjali Ayurved, co-founders".
  102. "Patanjali ads: Relief for Ramdev, Acharya Balakrishna as Supreme Court closes contempt case".
  103. "Ramdev turns his Ayurved enterprise into an FMCG empire". 28 June 2015.
  104. 104.0 104.1 104.2 104.3 "Here's Why Baba Ramdev Is Making Corporate India Uncomfortable". Indiatimes. 13 January 2015. Archived from the original on 15 January 2024. Retrieved 14 January 2024.
  105. "We plan to open Patanjali outlets at Railway stations, airports: Ramdev". 21 May 2015. Archived from the original on 15 January 2024. Retrieved 20 June 2015.
  106. Saini, Sonam (18 February 2019). "Patanjali's fashion foray: Baba Ramdev's company turns to apparel after creating ripples in FMCG". Financial Express. Archived from the original on 15 January 2024. Retrieved 26 May 2021.
  107. "Baba Ramdev expands empire beyond yoga to FMCG". The Economic Times. 13 January 2015. Archived from the original on 10 May 2015. Retrieved 18 January 2015.
  108. "Ramdev's Patanjali Ayurved enters big retail with Future Group tie-up". India Today.
  109. "Ramdev products available in Big bazaar". Nayi Duniya. 9 October 2015.
  110. "Future group and Patanjali tie-up". Patrika. 9 October 2015.
  111. "Future Group partners Patanjali Ayurveda". The Hindu. 9 October 2015. Archived from the original on 15 January 2024. Retrieved 14 October 2015.
  112. "Patanjali products to be sold in Khadi bhandars". Amar Ujala. 18 December 2014.
  113. "Baba Ramdev's Patanjali Ayurveda to make, sell DRDO food products". ABP Live. 25 August 2015.
  114. "Baba Ramdev's Patanjali Ayurveda To Sell DRDO Food Products". HuffPost India. 24 August 2015.
  115. [1] Archived 15 January 2024 at the Wayback Machine "Patanjali Ayurved to invest Rs 1,150 crores, eyes doubling revenue" The Hindu
  116. Dutta, Arnab (27 April 2016). "Baba Ramdev's Patanjali aims to double its revenue to Rs 10,000 cr in 2016-17". Business Standard India. Retrieved 16 March 2018 – via Business Standard.
  117. bureau, afaqs! news (5 September 2024). "Patanjali's ad spends increase by 145% YoY to Rs 424.7 crore in FY2024". afaqs!. Retrieved 5 September 2024. {{cite web}}: |last= has generic name (help)
  118. "Patanjali Completes Acquisition Of Ruchi Soya". BloombergQuint. 18 December 2019. Archived from the original on 15 January 2024. Retrieved 2 May 2020.

External links[edit | edit source]

  • {{URL|example.com|optional display text}}